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ABSTRACT 
 
The Effects of Poor Maternal Nutrition on Offspring Muscle Metabolism 
Dominique E. Martin 
University of Connecticut, 2018 
 
 
Poor maternal nutrition during gestation alters offspring muscle composition, fiber 
number, postnatal growth, and stem cell function. Additionally, poor maternal nutrition impacts 
offspring whole body and stem cell metabolism. We hypothesized that over- or restricted-feeding 
during gestation would alter muscle myoblast metabolism as well as offspring Longissimus dorsi 
muscle (LD) metabolome. Pregnant Western White-faced ewes (n = 47) were individually fed 
60% (RES), 100% (CON), or 140% (OVER) of NRC requirements starting at d 30.2 ± 0.2 of 
gestation. At d 90 and 135 of gestation, ewes were euthanized for fetal muscle collection. 
Another group of ewes were allowed to lamb and offspring were necropsied within 24 h of birth 
for offspring serum and muscle sample collection. C2C12 myoblasts were cultured in fetal serum 
to determine effects of poor maternal nutrition on cell proliferation, differentiation, and 
metabolism. Glycolytic function and mitochondrial respiration of C2C12 cells cultured in serum 
from CON, RES, and OVER lambs at birth were analyzed using the Seahorse Bioscience XF 
analyzer. Cell culture data were analyzed as a completely randomized design using PROC 
MIXED in SAS with main effects and interaction of gender and maternal diet. Mass 
spectrophotometry of LD samples (n = 8 fetuses per treatment per time point) identified 612 
metabolites. Metabolome data were analyzed by ANOVA for main effects of treatment, time 
point, and their interaction. There was no observed effect (P ≤ 0.05) of maternal diet on C2C12 
proliferation, fusion index, or glycolytic function. Proton leak was increased in C2C12 cells 
cultured in RES serum compared with CON (P = 0.04). For the metabolome analysis, compared 
with CON, maternal over-feeding altered metabolites in 63 pathways and maternal restricted-
x 
 
feeding altered metabolites in 56 pathways (P ≤ 0.05) in the offspring. Both maternal restricted- 
and over-feeding altered offspring metabolites in each of the 8 major metabolic pathways 
including amino acid, peptide, carbohydrate, energy, lipid, nucleotide, cofactors and vitamins, 
and xenobiotics. Maternal over-feeding decreased concentrations of 1 phosphatidylcholine (PC) 
metabolite at d 90, 2 PC metabolites at d 135, and 4 PC metabolites at birth compared with CON 
(P ≤ 0.05). Additionally, at d 135, maternal over-feeding increased 1 phosphatidylethanolamine 
(PE) metabolite while reducing 10 PE metabolites at birth compared with CON (P ≤ 0.05). 
Offspring from over-fed ewes had decreased concentrations of 12 lysolipids at birth compared 
with CON (P ≤ 0.05). Maternal restricted-feeding increased expression of reduced glutathione 
3.07-fold at d 90 (P = 0.008), whereas at d 135, oxidized glutathione was decreased 21% 
compared with CON (P = 0.03). Overall, poor maternal nutrition during gestation alters offspring 
metabolism. Specifically, maternal over-feeding may promote increased lipid oxidation in 
offspring muscle, which may predispose offspring to altered lipid utilization and storage 
postnatally. Maternal restricted-feeding resulted in alterations in glutathione metabolism, 
potentially indicative of changes to redox status in these offspring. 
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REVIEW OF LITERATURE 
Introduction 
Despite advancements in production techniques and management, livestock commonly 
face instances of restricted- and over-feeding (Thomas and Kott, 1995; Everett-Hincks and 
Dodds, 2007: Hoffman et al, 2017). Restricted nutrition can often arise due to different 
management practices as well as variations in feed quality (Thomas and Kott, 1995; Everett-
Hincks and Dodds, 2007). The quality of feed can be impacted by seasonal weather changes 
and/or limited forage availability or intake (Thomas and Kott, 1995; Hoffman et al., 2017). 
Production of sheep on a forage-based system is common, subjecting the animals to climate and 
forage fluctuations. Ewes are short-day breeders and typically gestate during the winter months 
when forage quality and abundance on the range is limited (Wu et al., 2004). Therefore, ewes 
raised on the range are susceptible to reduced forage quality and intake and often receive below 
50% of NRC nutritional requirements during the winter months in the Western United States 
(Thomas and Kott, 1995). Similarly, instances of over-nutrition can result due to different 
management and production systems of ruminant animals. Management systems in the Northeast 
or at Land Grant universities may provide more than sufficient nutrients, resulting in increased 
feed intake and over-conditioning during the winter months (Jobgen et al., 2008). Additionally, 
the practice of flushing, which is increasing the amount of feed before conception to encourage 
superovulation in ewes (National Research Council, 1985), leads to instances of over-nutrition. 
Other management practices also affect sheep productivity. The practice of selecting for 
fecundity, or increased offspring number, has increased over the last four decades (Everett-
Hincks and Dodds, 2007). This affects lamb survival since maternal nutrients and resources have 
to be partitioned to more offspring. Additionally, lamb mortality is greater in twin- and triplet-
born lambs compared with singletons (Johnson et al., 1982; Hinch et al., 1983; Scales et al., 
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1986; Hall et al., 1988). Although the increased mortality rate could be due to a variety of 
factors, maternal nutrition is an important contributor. Scales et al. (1986) demonstrated that 
when ewes bearing multiple offspring were offered additional feed during late pregnancy, lamb 
mortality was reduced.  
Proper fetal growth and development is dependent on maternal nutritional intake during 
gestation. Maternal nutrition is the diet a mother consumes before pregnancy, during gestation, 
and continued through lactation (American Journal of Public Health, 1973). Poor maternal 
nutrition can negatively impact offspring growth and development and is defined as inadequate 
or increased nutrient availability during gestation (Hoffman et al., 2017).  Both restricted- and 
over-feeding during gestation can result in programming of the offspring, which can lead to 
alterations in body size and birth weight of offspring, as well as impaired muscle growth, 
changes in adiposity, and altered metabolism (Hoffman et al., 2017).  Additionally, poor 
maternal nutrition has been shown to impair overall offspring growth and health. Both 
epidemiological and livestock studies have demonstrated that restricted- and over-feeding have 
long-lasting and detrimental effects on offspring productivity and health (Hales and Barker, 
2001; Wu et al., 2004). The Thrifty Phenotype Hypothesis, proposed by Hales and Barker 
(2001), is a classic example of programming. The hypothesis states when there is a period of 
maternal nutrient restriction during pregnancy, the developing fetus is exposed to inadequate 
nutrition, which results in programming so that the fetus is prepared to survive in an environment 
with limited nutrient supply later in life (Hales and Barker, 2001).  
Muscle is a tissue that is susceptible to programming in response to poor maternal 
nutrition (Reed et al., 2014). Muscle growth is a tightly regulated process controlled by 
numerous intrinsic and extrinsic factors. The majority of muscle development occurs during 
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gestation. During this time, animals undergo primary and secondary myogenesis to form muscle 
fibers, and the total number of muscle fibers an animal will have throughout the entirety of their 
life is set before birth (Rowe and Goldspink et al., 1969; Beerman et al., 1978; Wigmore and 
Stickland et al., 1983). After birth, the muscle fibers undergo hypertrophy where they increase in 
size but not in number (Rowe and Goldspink et al., 1969; Beerman et al., 1978; Wigmore and 
Stickland et al., 1983; White et al. 2010). Thus, the period of gestation is crucial for proper 
muscle development, and this tissue is susceptible to programming. Both meat quality, defined 
by factors such as tenderness, juiciness, and flavor, as well as meay quantity are important 
factors in marketable animals, and producers are interested in efficiently producing animals with 
the greatest amounts of high quality meat. The muscle itself is an extremely important tissue to 
the animal since it serves as an amino acid reservoir and is involved in metabolism (Brown et al., 
2014; Wolfe, 2006).  
Changes in muscle quantity and quality in response to poor maternal nutrition could be 
detrimental to production, efficiency, and animal health. Therefore, it is important to understand 
the factors and mechanisms that contribute to the programming of muscle. Production of healthy 
and efficient animals is necessary due to the rising demand quality protein sources. By 2050, the 
global population is expected to increase by 30% and reach 9.7 billion people (United Nations, 
2015). Livestock significantly contribute to the global food economy by providing dairy, egg, 
and meat products. The increase in population will result in an increased demand for animal 
products (Thorton 2010), and producers will have to meet this demand through more efficient 
animal production. Since poor maternal nutrition can have detrimental effects on livestock 
production, and therefore efficiency, it is essential to better understand the effects of 
programming.  
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Prenatal Muscle Development  
Myoblasts are first recruited from the mesenchyme and differentiate into muscle 
progenitor cells (MPCs; Pittenger et al., 1999; Biressi et al., 2007). Proliferating MPCs co-
express transcription factors Paired box 3 (Pax3) and 7 (Pax7; Biressi et al., 2007). In particular, 
Pax7 is an early marker of MPCs and is essential in maintaining these cells in a proliferative 
state (Zammit et al., 2016). Downregulation of Pax7 before differentiation is essential for 
progression through myogenesis (Zammit et al., 2006; Yablonka-Ruveni et al., 2008). Muscle 
progenitor cells will differentiate into muscle fibers through appropriate temporal expression of 
myogenic regulatory factors (MRFs), which drive the processes of proliferation and 
differentiation. These include myogenic factor 5 (MYF5), myogenic differentiation factor 1 
(MyoD), MRF4, and myogenin (Yablonka-Reuveni and Rivera, 1994). Myogenic regulatory 
factors drive the process of differentiation and are expressed in a sequential order to regulate 
muscle fiber formation (Berkes and Tapscott, 2005; Braun and Guatel, 2011). These four factors 
regulate myogenesis to form myotubes which mature into myofibers (Rehfeldt et al., 2004). 
Specifically, Myf5 and MyoD commit early progenitor cells to the muscle cell type. As 
differentiation proceeds, MyoD binds to myostatin, contributing to the withdrawal of the 
myoblast from the cell cycle along with the increased expression of myogenin (Spiller et al., 
2002; Singh and Dilworth, 2013). Myogenin and MRF4 later allow myoblasts to fuse and 
differentiate into muscle fibers (Rehfeldt et al., 2004). Myogenin and MRF4 target proteins that 
regulate the switch from proliferation to differentiation including retinoblastoma protein (RB), 
which inhibits cell cycle progression, and Cyclin D1 and cyclin dependent kinase-4 (CDK4), 
which regulate the cell cycle (Spiller et al., 2002). 
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Differentiation occurs in several waves, which generate primary and secondary fibers, 
and supports hypertrophy. The initial stage is primary myogenesis, where MPCs migrate and 
fuse before innervation, forming primary myofibers (Beerman et al., 1978). The second stage is 
termed secondary myogenesis and is dependent on innervation. Secondary fibers are derived 
from MPCs, which are originally maintained in a proliferating and undifferentiated state 
(Beerman et al., 1978). These MPCs then differentiate into myoblasts and fuse adjacent to 
primary myofibers to form secondary myofibers (Beerman et al., 1978). Myogenesis in sheep 
begins around d 20 of gestation and is completed between d 80 and 125 depending on the muscle 
(Ashmore et al., 1972, Fahey et al., 2005). Since all of the muscle fibers in the fetus are formed 
during gestation, there is no net increase in fiber number after birth, only fiber size (Rowe and 
Goldspink et al., 1969; Glore and Layman, 1983; Wigmore and Stickland et al., 1983; Nissen et 
al., 2003; Zhu et al., 2006; Rehfeldt et al., 2011).  
Establishment of skeletal muscle fiber type occurs during gestation (Phillips et al., 1986; 
Condon et al., 1990; Pette and Staron, 2001). Primary myofibers mainly express slow myosin 
heavy chain isoforms whereas secondary myofibers express fast myosin heavy chain isoforms 
which mature into Type II fibers (Pin et al., 2002). Fiber type determination occurs at the 
myoblast stage before fusion and myofiber formation. Different factors including myoblast 
lineage and innervation determine the muscle fiber type (DiMario and Stockdale, 1997). 
However, fiber types can switch due to various factors such as changes in insulin metabolism 
(Ryder et al., 2003), hormones (Staron et al., 2000), exercise (Henriksson 1992; Booth and 
Baldwin 1996), or the natural switch from embryonic to adult phenotypes (Whalen et al., 1984; 
Agbulut et al., 2003). This means that skeletal muscle fibers are capable of responding to altered 
functional and metabolic demands by changing their fiber type (Pette and Staron, 2001). 
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Postnatal Muscle Growth 
Muscle fibers continue to increase in size postnatally until maturity. During prenatal 
myogenesis, a portion of myogenic precursor cells remain undifferentiated in a quiescent state 
adjacent to the myofibers, allowing them to contribute to postnatal growth (Hawke and Garry, 
2001). At birth, these MPCs, termed satellite cells, account for up to 30% of total myofiber 
nuclei (Yin et al., 2013). In postnatal animals, satellite cells compose approximately 3 to 6% of 
total muscle nuclei (Yin et al., 2013). The increased satellite cell populations in early life 
contribute to early postnatal hypertrophy and become incorporated into the growing myofiber 
(Moss et al., 1971). Satellite cells are mononucleated and located between the basal lamina and 
the sarcolemma in the muscle (Moss and Leblond, 1971). Satellite cells possess their own plasma 
membrane, separate from membrane of the myofibers (Scharner et al., 2011). Satellite cells are 
distinct from general muscle nuclei, and distinguished by specific markers such as the 
transcription marker Pax7. They can also be identified by surface markers such as N-CAM, M-
cadherin, and CD34 (Biressi et al., 2010).  In mature animals, the satellite cells are usually 
quiescent except for times of injury, growth, or repair (Aloisi et al., 1973). Satellite cells are 
activated by several factors such as growth factors, production of sphingosine-1-phosphate, and 
mitogens (Bischoff, 1986; Kästner et al., 2000; Clemmons, 2009). When satellite cells are 
activated, their genetic expression changes, allowing for the upregulation of MRfs such as MyoD 
and myogenin (Pallafacchina et al., 2010). Satellite cells contribute to muscle mass by 
undergoing asymmetric division. In this process, a portion of the cells differentiate into 
myoblasts and contribute to the growing muscle fiber. The other portion of the population 
consists of undifferentiated cells which can replenish the quiescent satellite cell population 
(Biressi et al., 2010).  
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Factors Regulating Muscle Development  
Hormones and Growth Factors  
Hormones and growth factors have important roles in muscle development. For example, 
growth hormone (GH), in conjunction with insulin-like growth factor 1 (IGF-1), regulates 
postnatal muscle growth by increasing muscle mass and decreasing adiposity (Velloso et al., 
2008). The liver is primarily responsible for IGF-1 production, which is stimulated by GH 
release. For example, GH administration upregulated IGF-1 mRNA as well as protein in the liver 
(Matthews et al., 1986). There are also six IGF binding proteins (IGFBPs) that help modulate 
IGF activity in the tissues (Parker et al., 1998). When the GH/IGF axis is impaired, muscle 
growth is hindered (Baum et al., 1996; Sotiropoulos et al., 2006; Mavalli et al., 2010). Research 
demonstrates that when mice are lacking a GH receptor, they have decreased muscle mass and 
improper growth of myofibers (Baum et al., 1996; Sotiropoulos et al., 2006). The mice lacking 
the GH receptor also exhibit a reduction in circulating IGF-1. (Sotiropoulos et al., 2006).  In 
vitro, GH stimulates the proliferation of MPCs and fusion of myoblasts via the activation of IGF-
1 (Mavalli et al., 2010). Other hormones such as testosterone can influence muscle hypertrophy, 
whereas increased concentrations of corticosterone may cause atrophy (Crowley and Matt et al., 
1996). Growth factors, such as fibroblast growth factor (FGF), can also affect muscle growth and 
development. During gestation, the FGF family is expressed in the mesoderm, where FGFs have 
a vital role in the outgrowth of limbs (Olwin et al., 1994). The FGF family of proteins also is 
involved in regulating the balance between proliferation and differentiation of MPCs by 
activating MyoD (Hauschka et al., 1992).  
 
Amino Acids and the mTOR Pathway  
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A large portion of muscle hypertrophy takes place during late prenatal and early postnatal 
life, when fibers are rapidly growing, but this process continues throughout adulthood (Davis and 
Fiorotto, 2009). Protein accretion contributes to muscle hypertrophy and occurs during gestation 
and in postnatal growth. Protein accretion occurs when the rate of protein synthesis exceeds the 
rate of protein degradation (Schiaffano et al., 2013). Different factors regulate protein synthesis 
in the early neonatal life, but it is largely controlled by insulin signaling and amino acid sensing 
(Davis and Fiorotto, 2009). Circulating concentrations of insulin, amino acids, and glucose 
change in response to diet. Each of these factors stimulate skeletal muscle protein synthesis in 
the neonate (Davis and Fiorotto, 2009). Studies performed in vivo and in vitro demonstrate that 
insulin stimulates protein synthesis in the skeletal muscle and whole body (Liechty et al., 1992; 
Kimball et al., 1998; Wester et al., 2000; Brown and Hay, 2006).  
 Amino acids, especially leucine, serve as a signal for protein synthesis and are also 
precursors for proteins (Kimball and Jefferson, 2006). A postprandial increase in leucine, but not 
valine or isoleucine alone, stimulated muscle protein synthesis in neonatal pigs. However, the 
response to leucine was less than the synthesis response to a complete amino acid mixture 
(Escobar et al., 2005; 2006). The leucine-mediated response in protein synthesis involves the 
activation of the mammalian target of rapomycin (mTOR) pathway, and protein synthesis is 
partially regulated by mTOR. The mTOR complex 1 (mTORC1) is regulated by growth factors, 
energy status, oxygen, and amino acid concentrations and contributes to protein synthesis, lipid 
synthesis, and autophagy (Laplante and Sabatini, 2012). Specifically, amino acids, such as 
leucine and arginine, act as upstream signals to activate mTORC1 (Blommaart et al., 1995; Hara 
et al., 1998). Protein synthesis is directly regulated by mTORC1 since it phosphorylates the 
translational regulators eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-
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BP1) and S6 kinase 1 (S6K1), which then promote protein synthesis (Ma and Blenis, 2009). In 
addition to regulating muscle protein synthesis, mTORC1 is involved in the synthesis of lipids to 
generate membranes, and also positively regulates cellular energy metabolism and ATP 
production (Laplante and Sabatini, 2012).  
 
Muscle Metabolism  
Muscle and Inter-Organ Metabolism  
Skeletal muscle plays an integral role in metabolism and inter-organ crosstalk since it is 
involved with glucose and protein metabolism (Meyer et al., 2002). Skeletal muscle comprises 
40 to 50% of body mass, making it the most abundant insulin-sensitive tissue (Baron et al., 1988; 
DeFronzo et al., 1985; Zurlo et al., 1990). Additionally, skeletal muscle is responsible for 75 to 
95% of insulin mediated glucose disposal and is responsible for 20 to 30% of oxygen 
consumption (DeFronzo et al., 1985; Baron et al., 1988; Zurlo et al., 1990). Skeletal muscle also 
serves as an amino acid reservoir that sustains protein synthesis within the muscle and whole 
body (Wolfe, 2006). After a meal, approximately 40% of glucose is taken up by the muscle for 
storage as glycogen (Meyer et al., 2002). Glycogen storage facilitates rapid energy production 
for fiber contraction even when glucose is not available from the diet (Argiles et al., 2016). As 
stores of glycogen become depleted, increasing amounts of energy are generated through the 
process of gluconeogenesis (Shrayyef and Gerich, 2010). Muscle is essential for this process 
since during times of fasting, protein within muscle can be catabolized to provide energy 
substrates and essential amino acids (Frontera and Ochala, 2015). The regulation of glucose is 
essential for energy balance within the muscle and whole body. In the cytoplasm of cells, 
including skeletal muscle, the process of glycolysis generates energy substrates for ATP 
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production from glucose (Argiles et al., 2016). The liver and kidney also store glycogen, and 
glucose regulation by these three organs allows the body access to energy substrates. Interactions 
between the liver and muscle regulate carbohydrate metabolism and are largely responsible for 
achieving energy balance in the fed- and fasted-state (Argiles et al., 2016). Skeletal muscle is 
vital to metabolism and overall health since any changes to muscle mass, metabolic rate, 
hormone concentrations, or other circulating factors could significantly alter utilization of energy 
within the body.  
 
Fiber Type Metabolism  
Muscle metabolism is dictated by the characterization and distribution of fibers within 
that muscle (Scott et al., 2001). Muscle fiber types are classified based on their speed of 
contraction as well as their different need for energy substrates (Scott et al., 2001; Biressi et al., 
2007). Muscle fibers are composed of fibrillary proteins including actin and myosin, and 
different muscle fiber types have been classified based on morphological differences of these 
filaments. There are three main types of muscle fibers that contribute to skeletal muscle 
composition, although variations do occur (Scott et al., 2001). The main classifications are type I 
or slow-twitch oxidative, type IIa or fast-twitch oxidative, and type IIb or fast-twitch glycolytic 
(Pette et al. 2001). The terms “fast” and “slow” twitch refer to the speed of ATP hydrolysis and 
therefore, contraction within the fiber. The slow muscles have an increased myoglobin content 
which contributes to their darker red color, whereas the fast muscles have a reduced myoglobin 
concentration and appear white or lighter in color (McComas et al., 1996). The greater 
myoglobin content allows the slow muscle fibers to have a greater oxidative capacity and 
therefore rely on oxidative metabolism (McComas et al., 1996). Oxidative metabolism occurs 
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under aerobic conditions and produces 36 ATP per molecule of glucose. Additionally, slow 
twitch fibers have a greater density of capillaries and oxidative enzymes, making them more 
resistant to fatigue than fast twitch fiber types (Matsakas et al., 2009). Alternatively, the fast 
twitch type utilizes anaerobic metabolism, primarily glycolysis, to generate ATP (McComas et 
al., 1996). Glycolysis produces only two ATP per glucose molecule. This means that fast twitch 
muscles can contract more readily, but fatigue quicker than slow twitch muscles (Matsakas et al., 
2009). The differences in fiber types account for the different movements. Slow-twitch muscles 
are necessary for endurance exercise, whereas fast-twitch muscles are necessary for quick and 
powerful bursts of movement (Morrison et al., 1970).  Fiber types are not permanently fixed 
during gestation and throughout postnatal life. Muscle fibers can adapt to altered metabolic 
states, which in turn alters fiber type distribution and composition (Daniel et al., 2007; Maltin, 
2008; Schiffano et al., 2013). These changes to composition can then influence muscle 
metabolism as well as whole body metabolism.  
 
Poor Maternal Nutrition  
Both under- and over-feeding during gestation can negatively affect the offspring and 
impact both prenatal and postnatal muscle development (Ford et al., 2007). Although there is an 
increase in net muscle mass after birth due to hypertrophy, all of the muscle fibers are formed 
during gestation (Rowe and Goldspink et al., 1969; Beerman et al., 1978; Wigmore and 
Stickland et al., 1983; White et al. 2010). This makes muscle tissue particularly vulnerable to 
intrauterine conditions, maternal nutrition, and other factors that can influence muscle 
development (Zhu et al., 2006). Skeletal muscle is particularly susceptible to fetal programming 
because it is a lower priority tissue. Nutrients are first partitioned to organs such as the brain, 
12 
 
liver, and heart before muscle (Tchirikov et al., 1998; Yajnik, 2004). Therefore, to maintain vital 
organs, any nutritional insult to the mother during gestation can greatly impact muscle formation 
(Zhu et al., 2006).  
 
Nutrient Restriction  
Reduced feed intake during gestation can impact body and muscle composition as well as 
muscle fiber development. For example, dams who faced reduced nutrient intake during 
pregnancy produced lambs that were overall fatter and had reduced lean-to-fat ratios (Tygesen et 
al., 2007). A study conducted at the University of Connecticut demonstrated that in the 
semitendinosus muscle, lipid content was 92.5% greater in offspring from restricted animals 
compared with CON at birth. At 3 mo of age, restricted offspring showed a 23.6% decrease in 
lipid accumulation in the muscle compared with controls (Reed et al., 2014). This demonstrates 
that restricted-feeding alters lipid accumulation in the semitendinosus muscle and therefore 
muscle composition.   
Nutrient restriction can alter the total number of muscle fibers as well as the distribution 
of primary and secondary fibers. A study conducted by Zhu et al., (2004), found that a 50% NRC 
nutrient restriction in pregnant ewes from d 28 to 78 of gestation reduced the total number of 
secondary muscle fibers and also the ratio of primary to secondary muscle fibers in lambs (Zhu 
et al., 2004). These results indicate that fiber development is impaired in response to maternal 
restricted-feeding. Another study by Zhu et al. (2006) demonstrated that 8-mo-old lambs born to 
nutrient deficient mothers had fewer total muscle fibers than control animals (Zhu et al., 2006). 
In addition to impacting the number of fibers within the muscle, nutrient restriction can also alter 
the cross-sectional area (CSA) of muscle fibers. Underfeeding ewes during gestation impacted 
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offspring muscle CSA. For example, at birth and 3 mo of age, offspring from restricted-fed 
mothers weighed the same as offspring from control-fed mothers, but CSA was different (Reed 
et al., 2014). CSA of semitendinosus muscle fibers was 57% greater in restricted animals 
compared with control (Reed et al., 2014). However, at 3 mo of age, the muscle fiber CSA of the 
restricted lambs was reduced by 15% compared with controls (Reed et al., 2014). Maternal 
nutrient restriction during gestation similarly impairs cattle skeletal muscle, as demonstrated in a 
study conducted by Gonzalez et al. (2013). The fetal infraspinatus (INF) muscle was measured in 
calves from heifers fed 60% or 100% NRC from conception to either d 85 or 140 of gestation. At 
d 85 of gestation, the restricted offspring had increased muscle fiber CSA compared with the 
control group. At d 140, the restricted calves had reduced fiber CSA in the INF muscle 
(Gonzalez et al., 2013). 
Maternal nutrient-restriction can alter genetic expression of myogenic regulatory factors 
of the offspring. Even moderate maternal undernutrition negatively alters fetal muscle 
development by impacting the expression of myogenic regulatory factors in the muscle (Zou et 
al., 2016). Sows fed a low energy diet from d 1 to 90 of gestation had offspring with reduced 
fetal weights and decreased muscle fiber density. The low energy group had reduced mRNA 
expression of myogenin, MRF4, and creatine kinase compared with the control group at both d 
55 and 90 of gestation in the fetal pig (Zou et al., 2016). Further, restricted maternal diet can alter 
genes associated with muscle cell proliferation and signal transduction (Hoffman et al., 2016). 
These studies demonstrate that genes involved in myogenesis are altered due to poor maternal 
nutrition, which may result in changes to the muscle phenotype in offspring of restricted-fed 
dams.  
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Nutrient Excess 
Maternal over-nutrition during gestation also alters skeletal muscle development. 
Myogenesis and adipogenesis occur around the same time during gestation, and excess nutrients 
can affect both muscle and fat formation (Tong et al., 2009).  Maternal over-feeding during 
gestation can result in increased adipogenesis in the muscle and in the carcass as a whole, 
changing composition (Tong et al., 2009). Sows who were over-fed from conception to d 50 of 
gestation had piglets with increased adiposity in the muscle at birth (Daniel et al., 2007). Huang 
et al. (2012) also showed that maternal obesity during gestation produced offspring with 
increased collagen and cross-linking in the LD and semitendinosus muscle (Huang et al., 2012). 
The excess collagen and crosslinking reduces meat tenderness and makes it less palatable to the 
consumer. Further, sows who faced maternal over-nutrition during mid-gestation had offspring 
with impaired fiber development and reduced carcass quality (Cerisuelo et al., 2014). Lipid 
content in the semitendinosus muscle was 212.4% greater in offspring from over-fed ewes 
compared with the controls at birth. At 3 mo of age the over-fed animals had 36.1% greater lipid 
accumulation than control animals (Reed et al., 2014). These changes to composition could 
negatively impact muscle growth and metabolism.   
Maternal over-nutrition can also impact muscle fiber number and fiber distribution. Sows 
who were over-fed during gestation had piglets with reduced total, primary, and secondary 
fibers, demonstrating that over-feeding during gestation influences prenatal muscle fiber 
hyperplasia (Cerisuelo et al., 2014). Fiber diameter can also be reduced by maternal obesity. 
Specifically, at birth, lambs from obese ewes had reduced semitendinosus muscle fiber diameter 
compared with controls (Tong et al., 2009). Further, increased maternal nutrition during 
gestation altered skeletal muscle development in ovine offspring. From birth to 3 mo of age, the 
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lambs from over-fed mothers weighed 13% more than control lambs.  At birth, CSA of muscle 
fibers in the semitendinosus was 47% greater in offspring of over-fed animals compared with 
controls. At 3 mo of age, the CSA for the offspring of over-fed dams was reduced by 17% (Reed 
et al., 2014).  Thus, maternal over-nutrition during gestation impacts myogenesis, resulting in 
changes to muscle fiber number, fiber type distribution, and CSA.  
Maternal over-nutrition can also influence gene expression within the muscle. In cattle, 
maternal over-nutrition increased mRNA expression of adipogenic markers in skeletal muscle 
(Duarte et al., 2014). A study in sheep demonstrated that maternal obesity impaired myogenesis 
in the semitendinosus by downregulating myogenic markers including MyoD, myogenin and 
desmin in offspring from obese mothers compared with controls at birth (Tong et al., 2009). 
Additionally, maternal over-nutrition altered genes in offspring muscle related to protein 
synthesis, growth, and metabolism (Hoffman et al., 2016). Changes to gene expression can 
impact the skeletal muscle and demonstrate that maternal over-nutrition causes negative 
programming effects. The negative effects of maternal over-nutrition, including changes to 
composition, fiber number, fiber size, and gene expression can impact postnatal muscle growth 
and metabolism. 
  
Poor Maternal Nutrition and Stem Cell Function  
Poor maternal nutrition during gestation also alters stem cell populations in the offspring, 
specifically, satellite cells and mesenchymal stem cells. In mice, Woo et al. (2011) determined 
that offspring from restricted-fed mothers had altered muscle composition as well as changes in 
satellite cell numbers. Offspring of underfed dams had reduced overall muscle mass, but similar 
birth weights to control animals (Woo et al., 2011). Further, satellite cell numbers were reduced 
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by 33% in offspring of restricted-fed dams. Satellite cell function was examined later at 6 wk of 
age, since these muscle progenitor cells are essential for muscle repair and hypertrophy. During 
muscle regeneration, the number of regenerating fibers was reduced by 32% 3 d after injury in 
offspring of restricted-fed dams (Woo et al., 2011). Gonzalez et al. (2013) used cattle to 
demonstrated that a maternal restricted diet (60% of NRC requirements) reduced the number of 
Pax7 positive nuclei in offspring INF by almost 20% at d 85 of gestation, suggesting a loss of 
muscle progenitor cells. Additionally, offspring satellite cell function and subsequent 
hypertrophy is hindered by maternal restricted feeding (Raja et al., 2016).  Satellite cells are 
essential for postnatal muscle hypertrophy and muscle repair. Therefore, any insults during 
gestation can have lasting impacts of muscle growth. The results of these studies indicate that 
satellite cell populations and function are vulnerable to fetal programming.  
Mesenchymal stem cells are multipotent stem cells that contribute to the development of 
tissues including adipose, bone, and muscle. As part of the bone marrow niche, MSC help 
maintain and repair these tissues throughout adult life. MSC are responsive to changes in 
hormone and metabolite concentrations, and therefore susceptible to programming. Changes to 
maternal diet can cause MSC to favor differentiation into one cell lineage over another (Devlin 
and Bouxsein, 2012). Additionally, poor maternal nutrition, both restricted- and over-feeding, 
altered proliferation and metabolism of MSC (Pillai et al, 2016). Maternal restricted- and over-
feeding reduced MSC proliferation by 51% and 60%, respectively (Pillai et al., 2016). 
Mitochondrial basal respiration, ATP production, and maximal respiration were impacted by 
over- and under-feeding, indicating changes to the metabolism of the MSC due to maternal 
programming (Pillai et al., 2016).  Evidence supports that early perturbations to stem cell 
populations can have-long lasting impacts on muscle growth and development (Woo et al., 
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2011). Additionally, changes to these stem cell populations may provide insight into some of the 
mechanisms by which programming alters muscle metabolism and function.   
 
Effects of Poor Maternal Nutrition on Metabolism 
Whole body metabolism  
Poor maternal nutrition can cause changes to whole body metabolism, ultimately 
affecting muscle. Specifically, poor maternal nutrition alters the intrauterine environment and 
concentrations of offspring hormones and growth factors, thereby altering metabolism. For 
example, over- and under-feeding ewes during gestation resulted in lambs with decreased serum 
concentrations of IGF1 and IGF binding protein 3 at birth (Hoffman et al., 2014). Additionally, 
at 3 mo of age, offspring from over-fed ewes had increased leptin concentrations compared with 
restricted-fed offspring (Hoffman et al., 2016). In the same study, average insulin concentrations 
were increased over time in offspring from over-fed and restricted-fed ewes compared with 
controls (Hoffman et al., 2016).  Maternal under-nutrition also alters glucose tolerance in the 
offspring (Ford et al., 2007). Lambs born to restricted-fed ewes exhibited increased area under 
the curve for glucose and insulin at d 63 of age compared with control (Ford et al., 2007). 
Further, adult offspring of obese ewes had increased plasma glucose, insulin, and leptin 
concentrations after a twelve-week feeding challenge (Long et al., 2010). Early maternal under-
nutrition also results in altered metabolism. Specifically, maternal under-feeding resulted in 
reduced insulin sensitivity and increased insulin secretion in adult offspring (George et al., 
2011). Another study found that in sheep, early gestational under-nutrition caused a reduction in 
hepatic expression of gluconeogenic factors as well as reduced insulin sensitivity in the adipose 
tissue (Poore et al., 2014).  These changes to hormones, growth factors, and metabolism could be 
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mechanisms by which metabolism is programmed in response to poor maternal nutrition during 
gestation.  
 
Muscle Metabolism and Oxidative Stress 
 Not only does poor maternal nutrition affect whole body metabolism through changes to 
hormones and growth factor concentrations, there are specific programming effects on muscle 
metabolism and mitochondrial function. In rats, maternal obesity resulted in offspring with 
reduced skeletal muscle glucose transporter 4 (GLUT4) (Simar et al., 2012). There was also 
increased monocarboxylate transporter 1 (MCT1) protein (Simar et al., 2012). When these 
offspring continued on an obesogenic diet post-weaning, there were continued changes to the 
muscle. At 18 weeks of age, the offspring continued to have reduced muscle GLUT4 
concentrations, as well as decreased mRNA expression of carnitine palmitoyl transferase-1, and 
MyoD and myogenin protein expression (Simar et al., 2012). These findings demonstrate that 
maternal obesity could be influencing glucose metabolism and muscle specific gene expression.  
Poor maternal nutrition can alter mitochondrial function within skeletal muscle cells. 
Mitochondria generate ATP and are essential for cellular energy production and the regulation of 
cellular energy metabolism (Hanson, 1989). Both over- and restricted-feeding can alter offspring 
mitochondria. A study in mice demonstrated that male offspring from obese mothers had a 
decrease in mitochondrial complex II-III as well as impaired insulin signaling in the skeletal 
muscle (Shelley et al., 2009).  Another in pigs found that in-utero exposure to high energy diets 
decreased mitochondrial DNA content in skeletal muscle and downregulated mRNA 
concentrations of genes associated with mitochondrial biogenesis and function (Zou et al., 2017). 
Additionally, reduced maternal dietary energy intake decreased expression of genes involved in 
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mitochondrial biogenesis in the muscle, including peroxisome proliferator-activated receptor 
gamma coactivator 1α (PPARGC1A), nuclear respiratory factor 1 (NRF1), mitochondrial 
transcription factor A (TFAM), β subunit of mitochondrial H(+)-ATP synthase (ATB5B), sirtuin 
1 (Sirt1), and citrate synthase (CS; Zou et al., 2016).  
Poor maternal nutrition can affect the fiber type distribution, and therefore skeletal 
muscle metabolism in the offspring. For example, over-feeding during gestation altered fiber-
type proportions in porcine offspring by increasing the number of Type IIA fibers, leading to an 
increase in oxidative capacity. However there was no change to muscle fiber CSA or total fiber 
number (Markham et al., 2009). Over-feeding during gestation resulted in offspring that had a 
13.3% increase in type IIA fibers at birth (Reed et al., 2014). In contrast, restricted feeding 
during gestation resulted in offspring that had a 14.6% decrease in type IIA fibers at birth (Reed 
at al., 2014). Changes to fiber type distribution can have long-lasting impacts on muscle 
metabolism and can additionally result in changes to reactive oxygen species (ROS) and 
oxidative stress within the muscle (Jackson, 2005). During muscle contraction, free radicals are 
generated, resulting in oxidative damage to the tissue if not properly detoxified (Davies et al., 
1982).  Oxidative stress affects the mitochondria and myofibers of muscle, resulting in damage 
of the tissue (Davies et al., 1982). Oxidative stress can induce mitochondrial apoptosis (Giorgio 
et al., 2005). Due to their redox systems, type I fibers are more resistant to oxidative stress than 
type II fibers (Jackson, 2005). Therefore, an increase in type II fibers could indicate a decreased 
ability for the offspring to detoxify ROS in the muscle, further impacting growth and 
metabolism.  
Oxidative stress has many negative effects and can impact tissues such as muscle and 
adipose. The amount of ROS production and oxidative stress is dependent on different factors 
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such as the muscle fiber type composition and fat content in the muscle (Pinho et al., 2017). 
Oxidative stress alters satellite cell differentiation, causing more of these cells to join the 
adipocyte rather than the myogenic lineage (Vettor et al., 2009), resulting in increased adipose 
within the muscle. Increased oxidative stress is correlated with increased lipid peroxidation, 
resulting in mitochondrial damage and metabolic disruption (Davies et al., 1982).  
Oxidative stress is associated with muscle dysfunction. Studies indicate that 
mitochondrial uncoupling may be a protective mechanism to reduce ROS (Baynes et al., 1991; 
MacLellan et al., 2005). This is supported by experiments which demonstrate that mitochondrial 
uncoupling protein 3 (UCP3) upregulation reduces ROS production and facilitates fatty acid 
oxidation in L6 myocytes (MacLellan et al., 2005). In patients with type 2 diabetes, plasma 
hydroperoxides, a marker of oxidative stress, are increased and inversely correlated with 
glycemic control (Baynes et al., 1991). Other studies demonstrate that low-grade oxidant stress 
reduces insulin-stimulated glucose transport and insulin signaling in insulin sensitive cells such 
as L6 myocytes and 3T3-L1 adipocytes (Maddux et al., 2001; Rudich et al., 1997; Rudich et al., 
1998). Continuous evidence supports that oxidative stress is associated with impaired insulin 
action and metabolism in muscle.  
Poor maternal nutrition induces oxidative stress in offspring. Malti et al. (2014) 
demonstrated that mothers who were obese and had nutrient rich diets during gestation had 
increased oxidative stress. The offspring of these mothers also had increased amounts of 
oxidative stress, implicating a programming effect of maternal diet (Malti et al., 2014). Another 
study in humans demonstrated that children of mothers with increased body condition score 
(BCS) had increased lipid peroxidation and oxidative stress from ages 8 to 13 (Mohn et al., 
2007). Restricted maternal nutrition can similarly impact oxidative stress and the mechanisms in 
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place to modulate it. For example, He et al., (2012) demonstrated that when maternal protein is 
restricted, offspring had reduced antioxidant capacity. Even after a period of controlled feeding 
and nutrient recovery, these offspring still had impaired ability to detoxify free radicals, leading 
to increased oxidative stress (He et al., 2012). Further studies show that redox status is altered by 
poor maternal nutrition. Specifically, the expression of the antioxidant magnesium dependent 
superoxide dismutase is increased by maternal diet (Tarry-Adkins et al., 2016). Poor maternal 
nutrition during gestation may be altering skeletal muscle metabolism by contributing to changes 
in fiber type metabolism and inducing oxidative stress. 
 
Conclusion  
Optimal livestock production is dependent on proper gestational management and 
efficient offspring growth. As a result of poor maternal nutrition, changes to offspring mRNA 
and protein expression has the potential to reduce livestock growth rates and lean carcass mass, 
as well as impact the health of the offspring (Wu et al., 2004). Specifically, both under- and 
over-feeding can impact muscle formation, offspring metabolism, stem cell populations, and 
oxidative stress. Muscle is the meat product that consumers buy, and the demand for high quality 
protein will only increase as the population expands. Often, offspring from mothers who are 
either under- or over-nourished demonstrate divergent muscle phenotypes from control animals. 
Alterations to metabolism may be an underlying mechanism that drives these phenotypic 
changes. Therefore, it is important to investigate how poor maternal nutrition alters offspring 
muscle metabolism. We hypothesized that over- or restricted-feeding during gestation would 
alter muscle myoblast metabolism as well as offspring Longissimus dorsi muscle (LD) 
metabolome.  
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MATERIALS AND METHODS 
Animals  
All animal procedures were reviewed and approved by the University of Connecticut 
Institutional Animal Care and Use Committee (A13-059). Animal procedures were previously 
reported in Pillai et al. (2017). Multiparous Western White-faced ewes (n = 47), aged 3 years or 
older were estrus synchronized using a controlled intravaginal drug release device (CIDR; Easi-
Breed CIDR Sheep Insert, Zoetis, Parsippany, NJ). The CIDR was inserted intravaginally and 
removed from each ewe after 12 days. Following this, the ewes were given an intramuscular 
injection of PGF2α [Lutalyse, 5 mg/mL; Zoetis, Inc.; (Knights et al., 2001)]. The ewes were 
housed in a group and bred to 1 of 4 related Dorset rams. Day 0 of pregnancy was determined 
when ewes received a rump mark and showed no further evidence of remarking. Twenty days 
later, ewes were moved to 3 x 1 m individual pens that allowed visual but not physical contact 
with other ewes and individually fed.  Ewes were transitioned to a complete pelleted feed based 
on National Research Council (NRC) requirements for ewes gestating with twins, over a 7-day 
period starting at d 20. Using transabdominal ultrasound, 47 ewes were confirmed pregnant on d 
28.5 ± 0.4 (Jones et al., 2016). At d 30, ewes were randomly assigned to a 3 x 4 factorial 
arrangement of treatment structure with main effects of diet (3) and time point of gestation (4; n 
= 5 to 7 ewes per treatment). Pregnant ewes were fed either a control-fed (CON; 100% NRC; n = 
27), restricted-fed (RES; 60% NRC; n = 28), or over-fed diet (OVER; 140% NRC; n = 27) 
starting at d 30.2 ± 0.2 of gestation based on the NRC requirement for TDN (National Research 
Council, 1985). Based on ewe body weight, treatment diets (Central Connecticut Farmer’s 
COOP, Manchester, CT) of 60, 100, or 140% NRC were achieved by offering differing amounts 
of complete pelleted feed (Pillai et al., 2017). For each grain delivery (n = 3), analysis of 
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nutrients was completed by Dairy One (Ithaca, NY). Blocks containing sodium chloride and 
fresh water were freely available to the ewes. At the beginning of treatment and weekly 
thereafter, ewes were weighed and body condition score (BCS) was independently evaluated on 
a scale of 1-5 by 2 trained observers. Offspring born to control-, restricted-, or over-fed ewes are 
denoted as CON, RES and OVER, respectively. 
 
Sample Collection 
At d 90 and 135 of gestation, ewes (n = 5 to 7 per treatment combination) were weighed 
and euthanized. An intravenous injection of Beuthanasia-D Special (Merck Animal Health; 
Summit, NJ) containing 390 mg/mL sodium pentobarbitol and 50 mg/mL phenytoin based on 
body weight was given to each ewe. Following the injection, each ewe was exsanguinated as 
previously detailed (Reed et al., 2014). The fetuses were removed following a hysterectomy for 
necropsy and tissue analysis to evaluate the effects of restricted- and over-feeding on offspring 
development during gestation. A subset of ewes were allowed to undergo parturition (birth; n = 5 
to 7 per dietary treatment). Lambs were allowed to nurse colostrum for up to 24 hours after birth. 
Lambs were offered colostrum replacer (4 ewes total: 2 twin control litters and 2 twin restricted 
litters; DuMor Blue Ribbon Multi-Species Colostrum Supplement; Distributed by Tractor Supply 
Company, Brentwood, TN) if the ewe did not produce sufficient colostrum. Within 24 hours of 
birth, lambs were weighed and euthanized with an i.v. overdose of Beuthanasia-D Special (390 
ng/mL Sodium Pentobarbital and 50 mg/mL Phenytoin based on BW) and exsanguinated.  
Due to reasons unrelated to the study, four ewes did not complete the experiment. Five 
offspring were not viable and therefore not included in the experiment (2 mummified and 3 
stillborn). For the purposes of these experiments, a total of 72 offspring (n = 8 per treatment per 
24 
 
time point) from 47 ewes at d 90 and 135, and within 24 hours of birth were included in the final 
analysis.  
 Muscle samples from each offspring at d 90, 135, and birth were collected from the LD 
immediately after euthanasia and samples were immediately snap frozen in liquid nitrogen. 
Samples were stored at −80°C until further use. Whole blood was obtained from live lambs at the 
birth time point via jugular venipuncture and processed for serum within 24 hours of parturition.  
 
 
Figure 1. Experimental design, adapted from Pillai et al. (2017). To evaluate the effects of 
restricted- or over-feeding on offspring development during gestation, pregnant ewes (n = 82) 
were housed in individual pens on d 20 of gestation (Individual housing) and randomly assigned 
into a 3 × 4 factorial arrangement of treatments which began at d 30 of gestation (Diet). The 
treatment structure included 3 dietary levels (CON: 100% TDN; RES: 60% TDN; OVER: 140% 
TDN) and 4 time points during gestation (n = 5 to 7 ewes per treatment combination). At d 90 or 
135 of gestation, ewes were euthanized and the fetus(es) were removed for necropsy and tissue 
analysis. A third group of ewes underwent parturition (birth), after which lambs were necropsied 
within 24 h of parturition. 
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C2C12 Cell Culture 
Proliferation  
C2C12 cells (ATCC CRL-1772, Manassas, VA) were cultured in growth media 
containing Dulbecco’s modified Eagle medium (DMEM) with 4 g/L D-glucose (Gibco 
Laboratories, Gaithersburg, MD) and 10% fetal bovine serum (FBS), 1% penicillin/ 
streptomycin, 0.3% fungizone, and 0.2% gentamycin. Cells were passed once and plated on 24-
well plates at a density of 3,000 cells per well. Cells were allowed to attach and proliferate in 
growth media for 24 hours. After 24 hours, the media was changed so that the growth media 
contained 10% offspring serum instead of FBS. Serum collected from CON (n = 8), RES (n = 8), 
and OVER (n = 8) lambs at birth was added to media in duplicate wells. Each plate contained 
two wells cultured in growth media with FBS to serve as a plate control. Following the 
manufacturer’s instructions, after 48 hours, the cells were pulsed with 5-bromo-2'-deoxyuridine 
(BrdU) for 30 minutes (Click-iT EdU Alexa Fluor 488 Imaging Kit, Invitrogen, Carlsbad, CA), 
fixed with 4% paraformaldehyde, and immunostained to measure the percentage of cells in S-
phase. Cells were incubated with Hoescht 33342 for 1 hour to visualize nuclei. The cells were 
imaged using a Zeiss Observer, and 5 random images per well were taken. The percentage of 
proliferating cells was determined by the number of BrdU(+) cells divided by the total number of 
nuclei and multiplied by 100. Each experiment was replicated once. 
 
Differentiation  
C2C12 cells were cultured in growth media containing DMEM with 4 g/L D-glucose, 
10% FBS, 1 % penicillin/ streptomycin, 0.3% fungizone, and 0.2% gentamycin. Cells were 
passed once and plated onto 24-well plates at a density of 25,000 cells per well. Cells were 
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allowed to attach and proliferate in growth media for 72 hours to reach 100% confluency. After 
72 hours, the media was changed to differentiation media containing 2% offspring serum, 1% 
penicillin/ streptomycin, 0.3% fungizone, and 0.2% gentamycin. Serum from CON (n = 8), RES 
(n = 8), and OVER (n = 8) lambs was added to media in duplicate wells. C2C12 cells were 
cultured in their individual media and allowed to differentiate in treatment media for 5 days. 
Each plate contained two wells differentiated in differentiation media containing horse serum to 
serve as a plate control. To determine the effects of offspring serum on differentiation, myotubes 
were fixed with 4% paraformaldehyde and immunostained for myosin heavy chain (MyHC; 
Appendix 1). Hoescht 33342 was used to visualize nuclei. The cells were imaged using a Zeiss 
Observer, and 5 random images per well were taken. Fusion index was calculated as the number 
of nuclei within multinucleated MyHC-positive myotubes divided by the number of total number 
of nuclei and multiplied by 100.  Fiber diameter was calculated by determining the average width 
(diameter measured in 3 places) of MyHC-positive myofibers in each image. Each experiment 
was replicated once. 
 
Mitochondrial and Glycolytic Stress Assays  
Mitochondrial and glycolytic stress were evaluated using the Seahorse XFe24 
Extracellular Flux Analyzer (Seahorse Bioscience; North Billercia, MA) following 
manufacturer’s instructions and protocol. In brief, C2C12 cells were plated onto XFe24 culture 
plates at a density of 15,000 cells per well and cultured in 10% offspring serum in growth media 
[CON (n = 6), RES (n = 6), or OVER (n = 6)] for 24 hours. Twelve hours before the assay, the 
XFe24 sensor cartridges were hydrated with Seahorse Bioscience XFe24 Calibrant (pH 7.4) and 
stored at 37°C. 
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For the Cell Mito Stress Test Assay (Appendix II), 1 mM pyruvate (Sigma-Aldrich, St 
Louis, MO), 2 mM glutamine (Sigma-Aldrich), and 10 mM glucose (Sigma-Aldrich) were added 
to the assay medium, warmed to 37°C, pH was adjusted to 7.4 with 0.1 N NaOH, and the media 
was sterile filtered. Oligomycin, carbonyl cyanide-4 (trifluoromethoxy) phenylhydrazone 
(FCCP), and rotenone/antimycinA were re-suspended with 630 μL, 720 μL, and 540 μL of 
prepared assay medium, respectively. The injection ports were loaded using the constant volume 
method described in the manufacturer’s protocol. The maintenance medium was removed with a 
pipette, and each well was rinsed twice with assay media. Assay media (525 μL) was added to 
each well, and the cell culture plate was incubated at 37°C without CO2 for 60 minutes. The plate 
was then loaded into the Seahorse XFe24 Extracellular Flux Analyzer and the standard operating 
procedure for Cell Mito Stress Test Assay for the machine was followed according to 
manufacturer’s protocol to measure oxygen consumption rate (OCR). 
For the Glycolysis Stress Test Assay (Appendix III), 2 mM glutamine was added to 
Seahorse XF Assay Media (Seahorse Bioscience). The media was warmed to 37°C, pH was 
adjusted to 7.4 with 0.1 N NaOH, and the media was filter sterilized. The injection ports were 
loaded using the constant volume method described in the manufacturer’s protocol. The 
maintenance medium was removed with a pipette, and each well was rinsed twice with assay 
medium. Assay media (525 μL) was added to each well, and the cell culture plate was incubated 
at 37°C without CO2 for 60 minutes. The plate was then loaded into the Seahorse XFe24 
Extracellular Flux Analyzer. Standard operating procedure for Glycolysis Stress Test Assay for 
the machine was followed according to manufacturer’s protocol to measure extracellular 
acidification rate (ECAR). 
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The DNA content in individual wells on the XFe24 cell culture plates was quantified to 
account for variations in cell density using Macharey-Nagel NucleoSpin Tissue kits (Macharey-
Nagel Inc, Bethlehem, PA, USA), according to manufacturer’s protocol. The OCR and ECAR 
measurements were adjusted for total DNA content in each well.  
 
Metabolome Analysis  
Sample Preparation   
Longissimus dorsi samples (200 ng; n = 8 per treatment per time point) were shipped on 
dry ice to Metabolon, Inc. (Morrisville, NC) for metabolome analysis. Samples were prepared 
using the automated MicroLab STAR® system (Hamilton Company). Several recovery 
standards were added prior to the first step in the extraction process for quality control (QC) 
purposes. To remove protein, dissociate small molecules bound to protein or trapped in the 
precipitated protein matrix, and to recover chemically diverse metabolites, proteins were 
precipitated with methanol under vigorous shaking for 2 min (Glen Mills GenoGrinder 2000, 
SPEX Sample Prep, Metuchen, NJ) followed by centrifugation. The resulting extract was divided 
into five fractions: two for analysis by two separate reverse phase (RP)/ Ultra-performance liquid 
chromatography-tandem mass spectrometry (UPLC-MS/MS) methods with positive ion mode 
electrospray ionization (ESI), one for analysis by RP/UPLC-MS/MS with negative ion mode 
ESI, one for analysis by Hydrophilic Interaction Chromatography (HILIC)/UPLC-MS/MS with 
negative ion mode ESI, and one sample was reserved for backup. Samples were placed briefly on 
a TurboVap® (Zymark, Hopkinton, MA) to remove the organic solvent. The sample extracts 
were stored overnight under nitrogen before preparation for analysis.   
 
Quality Assurance/ Quality Control 
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Several types of controls were analyzed in concert with the experimental samples: a 
pooled matrix sample generated by taking a small volume of each experimental sample served as 
a technical replicate throughout the data set; extracted water samples served as process blanks; 
and a cocktail of QC standards that were carefully chosen not to interfere with the measurement 
of endogenous compounds were spiked into every analyzed sample allowed instrument 
performance monitoring and aided chromatographic alignment. Instrument variability was 
determined by calculating the median relative standard deviation (RSD) for the standards that 
were added to each sample prior to injection into the mass spectrometers. Overall process 
variability was determined by calculating the median RSD for all endogenous metabolites (i.e., 
non-instrument standards) present in 100% of the pooled matrix samples. Experimental samples 
were randomized across the platform run with QC samples spaced evenly among the injections. 
 
Ultrahigh Performance Liquid Chromatography-Tandem Mass Spectroscopy (UPLC-MS/MS)   
All methods utilized a Waters ACQUITY ultra-performance liquid chromatography 
(UPLC) and a Thermo Scientific Q-Exactive high resolution/accurate mass spectrometer 
interfaced with a heated electrospray ionization (HESI-II) source and Orbitrap mass analyzer 
operated at 35,000 mass resolution. The sample extract was dried then reconstituted in solvents 
compatible to each of the four methods. Each reconstitution solvent contained a series of 
standards at fixed concentrations to ensure injection and chromatographic consistency. One 
aliquot was analyzed using acidic positive ion conditions, chromatographically optimized for 
more hydrophilic compounds. In this method, the extract was gradient eluted from a C18 column 
(Waters UPLC BEH C18-2.1x100 mm, 1.7 µm) using water and methanol, containing 0.05% 
perfluoropentanoic acid (PFPA) and 0.1% formic acid (FA). Another aliquot was also analyzed 
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using acidic positive ion conditions; however it was chromatographically optimized for more 
hydrophobic compounds.  In this method, the extract was gradient eluted from the same afore 
mentioned C18 column using methanol, acetonitrile, water, 0.05% PFPA and 0.01% FA and was 
operated at an overall higher organic content. Another aliquot was analyzed using basic negative 
ion optimized conditions using a separate dedicated C18 column. The basic extracts were 
gradient eluted from the column using methanol and water, however with 6.5mM Ammonium 
Bicarbonate at pH 8. The fourth aliquot was analyzed via negative ionization following elution 
from a HILIC column (Waters UPLC BEH Amide 2.1x150 mm, 1.7 µm) using a gradient 
consisting of water and acetonitrile with 10mM Ammonium Formate, pH 10.8. The Mass Spec 
(MS) analysis alternated between MS and data-dependent sequential mass spectrometry (MSn) 
scans using dynamic exclusion. The scan range varied slighted between methods but covered 70-
1000 m/z.   
 
Data Extraction and Compound Identification 
Raw data were extracted, peak-identified and QC processed using Metabolon’s hardware 
and software. Compounds were identified by comparison to library entries of purified standards 
or recurrent unknown entities. Metabolon maintains a library based on authenticated standards 
that contains the retention time/index (RI), mass to charge ratio (m/z), and chromatographic data 
(including MS/MS spectral data) on all molecules present in the library. Furthermore, 
biochemical identifications are based on three criteria: retention index within a narrow RI 
window of the proposed identification, accurate mass match to the library +/- 10 ppm, and the 
MS/MS forward and reverse scores between the experimental data and authentic standards. The 
MS/MS scores are based on a comparison of the ions present in the experimental spectrum to the 
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ions present in the library spectrum. While there may be similarities between these molecules 
based on one of these factors, the use of all three data points can be utilized to distinguish and 
differentiate compounds.  More than 3,300 commercially available purified standard compounds 
have been acquired and registered into the laboratory information management system (LIMS) 
for analysis on all Metabolon platforms for determination of their analytical characteristics.  
 
Statistical Analysis  
Cell Culture Data 
All data were analyzed using PROC MIXED (SAS Inst. Inc., Cary, NC; version 9.4). 
Main effects of treatment, gender, and their interaction were analyzed and differences between 
means were determined using the pdiff statement in LSMEANS. Data are reported as mean ± 
SE. Main effects are discussed in the absence of a treatment by gender interaction. Significance 
is tested at P ≤ 0.05. 
 
Metabolome Data 
Data were analyzed using one-way ANOVA, two-way ANOVA, two-way repeated 
measures ANOVA, and correlation analysis to obtain P and q values. Statistical significance is 
declared for P-values less than 0.05. A principal components analysis was performed to find 
hierarchical clusterings of the data. Each principal component is a linear combination of every 
metabolite and the principal components are uncorrelated. The number of principal components 
is equal to the number of observations.  
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RESULTS 
 
Offspring serum alters C2C12 myoblast metabolism but not proliferation or differentiation 
Serum collected from offspring born to over- and restricted-fed ewes had no effect on 
BrDU incorporation (Figure 1) compared with CON (P ≥ 0.39; CON = 24.89 ± 3.03%, RES = 
24.06 ± 3.03%, OVER = 27.74 ± 3.03%). Additionally, serum collected from OVER and RES 
offspring had no effect on myofiber fusion index (Figure 2A; P ≥ 0.15; CON = 15.70 ± 2.87%, 
RES = 9.55 ± 3.23%, OVER = 10.97 ± 3.03%) or myofiber diameter (Figure 2B; P ≥ 0.70; CON 
= 15.38 ± 1.33 μm, RES = 14.88 ± 1.46 μm, OVER = 15.25 ± 1.38 μm) compared with CON.  
Serum from RES offspring increased proton leak (P = 0.01; Figure 3, CON = 14.98 ± 
1.81, RES = 22.33 ± 1.81 pmol O2 ·min
-1 ·µg-1 DNA), but serum from OVER offspring had no 
effect on proton leak (P = 0.57.; OVER = 16.45 ± 1.81 pmol O2 ·min
-1 ·µg-1 DNA ) compared 
with CON. Serum from offspring of restricted- and over-fed ewes had no effect on basal 
respiration (P ≥ 0.32; CON =  34.32 ± 3.88, RES = 44.87 ± 3.88, OVER = 35.38 ± 3.88, pmol O2 
·min-1 ·µg-1 DNA), ATP production (P ≥ 0.69; CON = 19.33 ± 3.21, RES = 22.54 ± 3.21, OVER 
= 18.94 ± 3.21 pmol O2 ·min
-1 ·µg-1 DNA), maximal respiration (P ≥ 0.17; CON = 177.15 ± 
49.83, RES = 303.21 ± 49.83, OVER = 182.58 ± 49.83 pmol O2 ·min
-1 ·µg-1 DNA), spare 
respiratory capacity (P ≥ 0.19; CON = 142.83 ± 47.79, RES = 258.34 ± 47.79, OVER = 147.19 ± 
47.79 pmol O2 ·min
-1 ·µg-1 DNA), or non-mitochondrial respiration (P ≥ 0.25; CON = 11.75 ± 
5.42, RES = 25.22 ± 5.42, OVER = 16.77 ± 5.42 pmol O2 ·min
-1 ·µg-1 DNA) compared with 
CON. There was no effect of gender (P ≥ 0.22) for any of the variables analyzed for 
mitochondrial function.  
Serum from offspring of restricted- and over-fed ewes had no effect on C2C12 glycolytic 
function (Figure 4). The variables of glycolysis (P ≥ 0.27; CON = 48.03 ± 4.08, RES = 45.21 ± 
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4.08, OVER = 41.39 ± 4.08 mPh ·min-1 ·µg-1 DNA), glycolytic capacity (P ≥ 0.51; CON = 51.41 
± 4.75, RES = 52.35 ± 4.75, OVER = 47.85 ± 4.75 mPh ·min-1 ·µg-1 DNA), glycolytic reserve (P 
≥ 0.19; CON = 3.38 ± 1.91, RES = 7.14 ± 1.91, OVER = 6.46 ± 1.91 mPh ·min-1 ·µg-1 DNA), 
and non-glycolytic acidification (P ≥ 0.40; CON = 15.63 ± 1.93, RES = 16.69 ± 1.93, OVER = 
14.33 ± 1.93  mPh ·min-1 ·µg-1 DNA) were not affected by treatment. There was no effect of 
gender (P ≥ 0.28) for any of the variables analyzed for glycolytic function.  
 
Muscle Metabolome Analysis  
 A total of 612 metabolites were detected in LM samples. Maternal diet altered metabolite 
concentrations at d 90, d 135, and birth (Table 1). At d 90, 86 metabolites were altered in RES 
offspring (P ≤ 0.05), 19 increased and 67 decreased, compared with CON. At d 135, 72 
metabolites were altered in RES offspring (P ≤ 0.05), 22 increased and 50 decreased, compared 
with CON. At birth, 64 metabolites were altered RES offspring (P ≤ 0.05), 14 increased and 50 
decreased, compared with CON. The OVER offspring had a total of 78 metabolites altered at d 
90 compared with CON (P ≤ 0.05), with 49 metabolites increased and 29 decreased. At d 135 
OVER offspring had 27 metabolites altered (P ≤ 0.05), 18 increased and 9 decreased, compared 
with CON. At birth, OVER offspring had 102 metabolites altered (P ≤ 0.05), 15 increased and 87 
decreased, compared with CON. At d 90 RES offspring had 104 metabolites altered (P ≤ 0.05), 
20 increased and 84 decreased, compared with OVER. At d 135, RES offspring had 118 
metabolites altered (P ≤ 0.05), 38 increased and 80 decreased, compared with OVER. At birth, 
RES offspring had 117 metabolites altered (P ≤ 0.05), 85 increased and 32 decreased, compared 
with OVER.  
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 Day of gestation altered metabolite concentrations within each treatment group (Table 2). 
In the CON treatment group, 362 metabolites were altered at d 90 compared with d 135, with 
200 increased and 162 decreased. A total of 436 metabolites were altered at d 90 compared with 
birth, with 191 increased and 245 decreased. Compared with birth, 374 metabolites were altered 
at d 135, with 127 increased and 247 decreased. In the RES treatment group, 376 metabolites 
were altered at d 90 compared with d 135, with 211 increased and 165 decreased. Compared with 
birth, 441 metabolites were altered at d 90, with 189 increased and 252 decreased. Additionally, 
374 metabolites were altered at d 135 compared with birth, with 129 increased and 245 
decreased. In the OVER treatment group, 374 metabolites were altered at d 90 compared with d 
135, with 219 increased and 155 decreased. A total of 441 metabolites were altered at d 90 
compared with birth, with 230 increased and 211 decreased. There were 365 metabolites altered 
at d 135 compared with birth, with 160 increased and 205 decreased. Principle component 
analysis of LM samples (Figure 5) demonstrated close clustering in response to day of gestation, 
indicating that time is the primary driver of variance between samples.  
Both maternal over- and restricted-feeding altered metabolites in each of the 8 major 
metabolic pathways (Table 3). For amino acid metabolism, and 63 of 161 identified metabolites 
were altered in OVER compared with CON (P < 0.05). For peptide metabolism, 6 of 17 
identified metabolites were altered in OVER compared with CON (P < 0.05). For carbohydrate 
metabolism, 12 of 39 identified metabolites were altered in OVER compared with CON (P < 
0.05). For energy metabolism, 1 of 11 identified metabolites were altered in OVER compared 
with CON (P < 0.05). For lipid metabolism 70 of 268 identified metabolites were altered in 
OVER compared with CON (P < 0.05). For nucleotide metabolism 10 of 56 identified 
metabolites were altered in OVER compared with CON (P < 0.05). For cofactors and vitamins, 
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15 of 31 identified metabolites were altered in OVER compared with CON (P < 0.05). For 
xenobiotics, 10 of 29 identified metabolites were altered in OVER compared with CON (P < 
0.05). Maternal restricted-feeding additionally altered metabolites in each of the 8 major 
metabolic pathways. For amino acid metabolism, 53 of 161 metabolites were altered in RES 
compared with CON (P < 0.05). For peptide metabolism, 4 of 17 metabolites were altered in 
RES compared with CON (P < 0.05). For carbohydrate metabolism, 8 of 39 metabolites were 
altered in RES compared with CON (P < 0.05). For energy metabolism, 1 of 11 metabolites were 
altered in RES compared with CON (P < 0.05). For lipid metabolism 89 of 268 metabolites were 
altered in RES compared with CON (P < 0.05). For Nucleotide metabolism 16 of 56 metabolites 
were altered in RES compared with CON (P < 0.05). For cofactors and vitamins, 12 of 31 
metabolites were altered in RES compared with CON (P < 0.05). For xenobiotics, 13 of 29 
metabolites were altered in RES compared with CON (P < 0.05). 
A total of 43 pathways were altered by the interaction of treatment and time, including 
fatty acid metabolism, lysophospholipid metabolism, and sphingolipid metabolism (Table 4). 
Maternal diet altered 51 pathways, including phosphatidylethanolamine metabolism, histidine 
metabolism, and phosphatidylcholine metabolism (Table 5). Day of gestation altered 85 
pathways including ceramide metabolism, diacylglycerol metabolism, acyl carnitine metabolism, 
and branched chain amino acid metabolism (Table 6). In RES offspring, 33 pathways were 
altered at d 90 (Table 7, 39 pathways were altered at d 135 (Table 8), and 32 pathways were 
altered at birth (Table 9) compared with CON. In OVER offspring, 40 pathways were altered at d 
90 (Table 10), 19 pathways were altered at d 135 (Table 11), and 43 pathways were altered at 
birth (Table 12) compared with CON.  
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Maternal over-feeding alters carbohydrate metabolism in the offspring  
Maternal over-feeding altered N6-carboxymethyllysine, an advanced glycation end 
product, in the offspring (Figure 6). No changes were observed between OVER and CON at d 90 
or 135, but at birth, N6-carboxymethyllysine was increased 1.61-fold compared with CON (P = 
0.02).  
 
Maternal over-feeding alters amino acid metabolism in the offspring  
Increased maternal nutrient consumption altered alanine and aspartate metabolism in the 
offspring (Figure 7). At d 90, alanine was increased (fold change = 1.21; P = 0.03) in OVER 
compared with CON. However, N-acetylasparagine (fold change = 0.56; P = 0.001) and 
hydroxyasparagine (fold change = 0.75; P = 0.04) were decreased in OVER compared with 
CON. At d 135 N-acetylaspartate (NAA; fold change = 0.63; P = 0.03) was decreased. At birth 
N-methylalanine (fold change = 1.32; P = 0.04) was increased, and alanine (fold change = 0.80; 
P = 0.01), N-acetylalanine (fold change = 0.71; P = 0.001), aspartate (fold change = 0.60; P = 
0.002), asparagine (fold change = 0.66; P = 0.02), and hydroxyasparagine (fold change = 0.72; P 
= 0.03) were decreased in OVER compared with CON.  
The OVER offspring also exhibited changes to glutathione metabolism (Figure 8).  At d 
90, reduced glutathione (GSH; fold change = 2.62; P = 0.005), was increased in OVER 
compared with CON, while cystine-glutathione disulfide (fold change = 0.36; P = 0.04) and 2-
aminobutyrate (fold change = 0.54; P = 0.03) were increased. At d 135, opthalmate (fold change 
= 0.38; P = 0.0002) was decreased, and at birth S-methylglutathione (fold change = 0.61; P = 
0.04) was decreased in OVER compared with CON. 
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Increased maternal nutrient consumption impacted histidine metabolism (Figure 9). At d 
90, maternal over-feeding increased carnosine (fold change = 1.18; P = 0.03) and decreased 1-
methylhistidine (fold change = 0.57; P = 0.007), 3-methylhistidine (fold change = 0.60; P = 
0.007), and N-acetyl-1-methylhistidine (fold change = 0.25; P = 0.00001) compared with CON. 
At d 135, OVER offspring exhibited increased imidazole propionate (fold change = 2.73; P = 
0.03) and formiminoglutamate (fold change = 2.27; P = 0.05) compared with CON. At birth, 1-
methylhistamine was decreased 0.50-fold (P = 0.03) in OVER compared with CON.  
Maternal over-feeding resulted in changes to leucine, isoleucine and valine metabolism in 
the offspring muscle (Figure 10). 4-methyl-2-oxopentanoate (fold change = 0.56; P = 0.04) was 
decreased, whereas beta-hydroxyisovalerate (fold change = 2.09; P = 0.002), beta-
hydroxyisovaleroylcarnitine (fold change = 1.56; P = 0.01), 3-methylglutaconate (fold change = 
1.89; P = 0.01), and 3-hydroxyisobutyrate (fold change = 1.58; P = 0.02) were increased at d 90 
in OVER compared with CON. At d 135, beta-hydroxyisovalerate (fold change = 1.58; P = 
0.02), 3-methylglutaconate (fold change = 1.76; P = 0.01), and 3-hydroxyisobutyrate (fold 
change = 1.59; P = 0.01) continued to be increased.  
The OVER offspring exhibited divergent tryptophan metabolism (Figure 11). N-
formylanthranilic acid (fold change = 2.16; P = 0.01) and indolelactate (fold change = 1.68; P = 
0.007) were increased while 3-indoxyl sulfate (fold change = 0.59; P = 0.04) was decreased at d 
90 in OVER compared with CON. Indolelactate (fold change = 1.58; P = 0.01) was increased at 
d 135 in OVER offspring. A birth, indoleacetate (fold change = 0.49; P = 0.05) and 3-indoxyl 
sulfate (fold change = 0.36; P = 0.0003) were decreased in offspring from over-fed ewes when 
compared with CON.  
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Finally, maternal over-feeding caused changes to tyrosine metabolism in the offspring 
(Figure 12). Tyrosine (fold change = 1.41; P = 0.02), 3-(4-hydroxyphenyl)lactate (fold change = 
1.90; P = 0.001), and phenol sulfate (fold change = 1.44; P = 0.04) were increased at d 90 in 
OVER compared with CON, while 3-methoxytyrosine (fold change = 0.49; P = 0.01)  was 
decreased. 3-methoxytyrosine (fold change = 0.60; P = 0.03) continued to be decreased in OVER 
at d 135. There were no changes observed at birth.  
 
Maternal over-feeding alters offspring lipid metabolism 
Over-feeding altered fatty acid and branched chain amino acid metabolism at birth by 
decreasing propionylcarnitine (C3) 0.35-fold (P = 0.01; Figure 13). Maternal over-feeding 
caused no changes to this pathway at d 90 and 135. Offspring of over-fed ewes exhibited 
changes to fatty acid and acyl carnitine metabolism (Figure 14).  At d 90 and 135, no metabolites 
involved in fatty acid and acyl carnitine metabolism were altered compared with CON. However, 
at birth, 3-hydroxybutyrylcarnitine was increased 1.76-fold (P = 0.04). At the same time-point, 
OVER exhibited decreased 5-dodecenoylcarnitine (C12:1; fold change = 0.55; P = 0.003), 
linolenoylcarnitine (C18:3; fold change = 0.78; P = 0.006), myristoleoylcarnitine (C14:1; fold 
change = 0.60; P = 0.02), adrenoylcarnitine (C22:4; fold change = 0.45; P = 0.001), 
behenoylcarnitine (C22; fold change = 0.46; P = 0.01), docosatrienoylcarnitine (C22:3; fold 
change = 0.54; P = 0.01), docosapentaenoylcarnitine (C22:5n3; fold change = 0.44; P = 0.0009), 
docosahexaenoylcarnitine (C22:6; fold change = 0.61; P = 0.005), margaroylcarnitine (C17; fold 
change = 0.67; P = 0.03), and nervonoylcarnitine (C24:1)  (fold change = 0.34; P = 0.003) 
compared with CON. 
39 
 
Lysophospholipid metabolism was altered by maternal over-feeding, especially at birth 
(Figure 15). At d 90, 1-palmitoleoyl-GPC (16:1; fold change = 1.22; P = 0.03) and 1-oleoyl-GPG 
(18:1; fold change = 1.39; P = 0.02) were increased in OVER compared with CON. No changes 
were identified at d 135. However, at birth, 13 lysophospholipid metabolites were decreased 
compared with CON [1-palmitoyl-GPC (16:0; fold change = 0.82; P = 0.03), 1-palmitoleoyl-
GPC (16:1; fold change = 0.82; P = 0.04), 1-stearoyl-GPC (18:0; fold change = 0.75; P = 0.005), 
1-oleoyl-GPC (18:1; fold change = 0.76; P = 0.0008), 1-linoleoyl-GPC (18:2; fold change = 
0.54; P = 0.005), 1-palmitoyl-GPE (16:0; fold change = 0.63; P = 0.0001), 1-stearoyl-GPE (18:0; 
fold change = 0.71; P = 0.0003), 1-oleoyl-GPE (18:1; fold change = 0.75; P = 0.0006), 1-
linoleoyl-GPE (18:2; fold change 0.51= ; P = 0.0008), 1-arachidonoyl-GPE (20:4n6; fold change 
= 0.65; P = 0.02), 1-palmitoyl-GPI (16:0; fold change = 0.68; P = 0.03), 1-stearoyl-GPI (18:0; 
fold change = 0.63; P = 0.02), and 1-oleoyl-GPI (18:1; fold change = 0.61; P = 0.02)].  
Maternal over-feeding also caused extensive changes to metabolites involved 
phosphatidylethanolamine metabolism, especially at the birth time-point (Figure 16). No changes 
were identified at d 90. At d 135, 1,2-dipalmitoyl-GPE (16:0/16:0; fold change = 1.44; P = 0.01) 
was increased at in OVER compared with CON. At birth, 10 of 11 metabolites identified in this 
pathway were decreased in OVER compared with CON [1-palmitoyl-2-oleoyl-GPE (16:0/18:1; 
fold change = 0.68; P = 0.002), 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4; fold change = 0.61; 
P = 0.002), 1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6; fold change = 0.54; P = 0.002), 1-
palmitoleoyl-2-oleoyl-GPE (16:1/18:1; fold change = 0.68; P = 0.006), 1-stearoyl-2-oleoyl-GPE 
(18:0/18:1; fold change = 0.67; P = 0.0), 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4; fold change 
= 0.70; P = 0.0), 1,2-dioleoyl-GPE (18:1/18:1; fold change = 0.67; P = 0.005), 1-oleoyl-2-
linoleoyl-GPE (18:1/18:2; fold change = 0.47; P = 0.01), 1-oleoyl-2-arachidonoyl-GPE 
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(18:1/20:4; fold change = 0.73; P = 0.006), and 1-oleoyl-2-docosahexaenoyl-GPE (18:1/22:6; 
fold change = 0.73; P = 0.03)].  
 
Maternal restricted-feeding alters offspring amino acid metabolism  
Lambs born to restricted-fed ewes exhibited changes in muscle glutamate metabolism 
(Figure 17). Glutamate, gamma-methyl ester (fold change = 1.53; P = 0.006) and gamma-
aminobutyrate (GABA; fold change = 1.27; P = 0.03) were increased at d 90 in RES compared 
with CON. Glutamate (fold change = 0.85; P = 0.03) was decreased at d 135 and remained 
decreased at birth (fold change = 0.78; P = 0.0006) along with N-methyl-GABA (fold change = 
0.64; P = 0.006) in RES compared with CON.  
Glutathione metabolism was also impacted by restricted-maternal diet (Figure 18). At d 
90, reduced glutathione (GSH) was increased 3.07-fold (P = 0.008), and 2-aminobutyrate was 
decreased 0.54-fold (P = 0.005) in RES compared with CON. At d 135, oxidized glutathione 
(GSSG) was decreased 0.21-fold (P = 0.02) and 2-aminobutyrate (P = 0.001) was increased 
1.93-fold in RES compared with CON. There were no changes to glutathione metabolism at birth 
in offspring from restricted-fed mothers.  
Restricted-feeding altered offspring muscle histidine metabolism (Figure 19). No changes 
were observed at d 90. However, at d 135, 1-methylhistidine (fold change = 2.69; P = 0.00001), 
3-methylhistidine (fold change = 3.38; P = 0.00001), N-acetyl-1-methylhistidine (fold change = 
3.74; P = 0.0), formiminoglutamate (fold change = 2.95; P = 0.00001), and anserine (fold change 
= 1.41; P = 0.003) were increased while imidazole propionate (fold change = 0.20; P = 0.008) 
and carnosine (fold change = 0.85; P = 0.03) were decreased in RES compared with CON. 
Additionally, at birth, imidazole lactate (fold change = 0.64; P = 0.05), carnosine (fold change = 
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0.80; P = 0.003), anserine (fold change = 0.80; P = 0.03), and 1-methyl-4-imidazoleacetate (fold 
change = 0.63; P = 0.03) were all decreased in RES compared with CON.  
 
Maternal restricted-feeding alters offspring lipid metabolism  
Maternal restricted-nutrition caused reductions to offspring lysophosphlipids at all time 
points (Figure 20). At d 90, 1-palmitoyl-GPE (16:0; fold change = 0.81; P = 0.04) and 1-
stearoyl-GPE (18:0; fold change = 0.83; P = 0.05) were decreased in RES compared with CON. 
At d 135, 1-stearoyl-GPE (18:0; fold change = 0.68; P = 0.001), 1-stearoyl-GPE (18:0; fold 
change = 0.51; P = 0.00001), and 1-stearoyl-GPI (18:0; fold change = 0.58; P = 0.0003) were 
decreased in RES compared with CON. At birth, 1-palmitoyl-GPC (16:0; fold change = 0.75; P 
= 0.002), 1-palmitoleoyl-GPC (16:1; fold change = 0.72; P = 0.0007), 1-stearoyl-GPC (18:0; 
fold change = 0.81; P = 0.02), 1-oleoyl-GPC (18:1; fold change = 0.83; P = 0.009), 1-palmitoyl-
GPE (16:0; fold change = 0.80; P = 0.05), 1-stearoyl-GPE (18:0; fold change = 0.70; P = 
0.0001), and 1-oleoyl-GPE (18:1; fold change = 0.84; P = 0.02) were all decreased in RES 
compared with CON. 
 Restricted-feeding cause changes in offspring phosphatidylcholine metabolism at all 
time points (Figure 21). 1-palmitoyl-2-oleoyl-GPC (16:0/18:1; fold change = 0.84; P = 0.005), 1-
palmitoyl-2-linoleoyl-GPC (16:0/18:2; fold change = 0.84; P = 0.01), 1-palmitoyl-2-dihomo-
linolenoyl-GPC (16:0/20:3n3 or 6; fold change = 0.66; P = 0.0002), 1-stearoyl-2-oleoyl-GPC 
(18:0/18:1; fold change = 0.75; P = 0.004), and 1,2-dioleoyl-GPC (18:1/18:1; fold change = 
0.86; P = 0.008) were all reduced at d 90 in RES compared with CON. At d 135, 1-palmitoyl-2-
palmitoleoyl-GPC (16:0/16:1; fold change = 0.84; P = 0.04) was decreased and 1-palmitoleoyl-
2-linolenoyl-GPC (16:1/18:3; fold change = 1.39; P = 0.04) was increased in RES compared 
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with CON. Additionally, at birth, 1-myristoyl-2-palmitoyl-GPC (14:0/16:0; fold change = 0.81; 
P = 0.03), 1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1; fold change = 0.76; P = 0.002), 1-
palmitoyl-2-oleoyl-GPC (16:0/18:1; fold change = 0.87; P = 0.03), and 1-palmitoyl-2-dihomo-
linolenoyl-GPC (16:0/20:3n3 or 6; fold change = 0.81; P = 0.04) were all decreased in RES 
compared with CON.  
There were also changes in phosphatidylethanolamine metabolism in response to 
maternal restricted-nutrition (Figure 22). At d 90, 1-palmitoyl-2-oleoyl-GPE (16:0/18:1; fold 
change = 0.73; P = 0.007), 1-palmitoleoyl-2-oleoyl-GPE (16:1/18:1; fold change = 0.72; P = 
0.02), 1-stearoyl-2-oleoyl-GPE (18:0/18:1; fold change = 0.70; P = 0.007), and 1,2-dioleoyl-GPE 
(18:1/18:1; fold change = 0.77; P = 0.01) were reduced in RES compared with CON. Despite 
seeing no changes to any metabolites at d 135, 1-palmitoleoyl-2-oleoyl-GPE (16:1/18:1; fold 
change = 0.75; P = 0.03) was again reduced at birth in RES compared with CON.  
Finally, restricted-feeding resulted in broad changes to offspring sphingolipid 
metabolism, especially at d 90 (Figure 23). Myristoyl dihydrosphingomyelin (d18:0/14:0; fold 
change = 0.71; P = 0.01), palmitoyl dihydrosphingomyelin (d18:0/16:0; fold change = 0.65; P = 
0.0004), palmitoyl sphingomyelin (d18:1/16:0; fold change = 0.84; P = 0.005), stearoyl 
sphingomyelin (d18:1/18:0; fold change = 0.82; P = 0.008), behenoyl sphingomyelin 
(d18:1/22:0; fold change = 0.56; P = 0.0002), tricosanoyl sphingomyelin (d18:1/23:0; fold 
change = 0.50; P = 0.0004), lignoceroyl sphingomyelin (d18:1/24:0; fold change = 0.55; P = 
0.0007), sphingomyelin (d18:1/17:0, d17:1/18:0, d19:1/16:0; fold change = 0.75; P = 0.009), 
sphingomyelin (d18:1/20:0, d16:1/22:0; fold change = 0.65; P = 0.003), sphingomyelin 
(d18:1/20:1, d18:2/20:0; fold change = 0.73; P = 0.007), sphingomyelin (d18:1/22:1, d18:2/22:0, 
d16:1/24:1; fold change = 0.68; P = 0.002), sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1; 
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fold change = 0.68; P = 0.03), sphingomyelin (d18:1/24:1, d18:2/24:0; fold change = 0.64; P = 
0.006), sphingomyelin (d18:2/24:1, d18:1/24:2; fold change = 0.77; P = 0.03), sphingomyelin 
(d18:0/18:0, d19:0/17:0; fold change = 0.58; P = 0.001), and sphingomyelin (d18:1/19:0, 
d19:1/18:0; fold change = 0.57; P = 0.02) were decreased at d 90 in RES compared with CON. 
At d 135, sphingomyelin (d18:2/14:0, d18:1/14:1; fold change = 1.24; P = 0.02) and 
sphingomyelin (d18:2/24:2; fold change = 2.02; P = 0.002) were increased, whereas at birth, 
sphingomyelin (d18:1/20:1, d18:2/20:0; fold change = 0.80; P = 0.007) and sphingomyelin 
(d18:1/19:0, d19:1/18:0; fold change = 0.61; P = 0.04) were decreased in RES compared with 
CON. 
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Figure 1: Serum from offspring of poorly nourished ewes does not alter C2C12 proliferation. 
C2C12 cells were cultured in serum collected from offspring of CON (n = 6), RES (n = 6), or OVER (n = 
6) ewes at birth. Percentage of cells in s-phase was measured by 5-bromo-2'-deoxyuridine (BrdU) 
incorporation in C2C12 cells cultured in offspring serum for 48 hours. Cells were cultured in duplicate 
wells, and the experiment was replicated once. Data are presented as mean ± standard error.   
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Figure 2: Serum from offspring of poorly nourished ewes does not alter C2C12 
differentiation. C2C12 cells were cultured in serum collected from offspring of CON (n = 6), RES (n = 
6), or OVER (n = 6) ewes at birth. The fusion index (A) and myofiber diameter (B) of differentiated 
C2C12 myofibers cultured in offspring serum for 5 days were calculated. Cells were cultured in 
duplicate wells, and the experiment was replicated once. Data are presented as mean ± standard 
error.   
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Figure 3: Serum from offspring born to restricted-fed ewes alters C2C12 mitochondrial 
respiration. C2C12 cells were cultured in serum collected from offspring of CON (n = 6), RES (n = 6), 
or OVER (n = 6) ewes at birth. (A) Oxygen Consumption Rate (OCR), an indicator of oxygen-
dependent mitochondrial ATP production, was measured when C2C12 cells were successively 
exposed to oligomycin, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), and 
rotenone/antimycin. (B) Calculation of non-mitochondrial respiration, basal respiration, proton 
leak, ATP production, maximal respiration, and spare respiratory capacity of C2C12. Data are 
presented as mean ± standard error. * denotes P ≤ 0.05 compared with CON.   
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Figure 4: Serum from offspring of poorly nourished ewes does not alter C2C12 glycolytic 
function. C2C12 cells were cultured in serum collected from offspring of control-fed (CON, n = 
6), restricted (RES, n = 6), or over-fed (OVER, n = 6) ewes at birth. Extracellular Acidification 
Rate (ECAR), an indication of glycolysis, was measured when C2C12 cells were sequentially 
exposed to glucose, oligomycin, and 2-deoxy-D-glucose (2-DG).   
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Table 1. Number of fetal metabolites in LD altered by maternal diet.  
1 Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet. 
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30 
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was 
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes 
allowed to undergo parturition. 
 
 
  
 Metabolites 
P ≤ 0.05 
Metabolites 
0.05 < P ≤ 0.1 
Diet Time Total Increased Decreased Total Increased Decreased 
RES/CON 
 
d 90 86 19 67 35 9 26 
d 135 72 22 50 28 6 22 
Birth 64 14 50 41 12 29 
OVER/CON 
 
d 90 78 49 29 30 20 10 
d 135 27 18 9 22 13 9 
Birth 102 15 87 50 9 41 
RES/OVER 
 
d 90 104 20 84 39 9 30 
d 135 118 38 80 38 13 25 
Birth 117 85 32 56 44 12 
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Table 2. Number of fetal metabolites in LD altered by day of gestation. 
 Metabolites 
P ≤ 0.05 
Metabolites 
0.05 < P ≤ 0.1 
Diet Time Total Increased Decreased Total Increased Decreased 
CON 
 
d 90/d 135 362 200 162 28 15 13 
d 90/Birth 436 191 245 29 13 16 
d 135/Birth 374 127 247 35 17 18 
RES 
 
d 90/d 135 376 211 165 31 15 16 
d 90/Birth 441 189 252 32 15 17 
d 135/Birth 374 129 245 33 17 16 
OVER 
 
d 90/d 135 374 219 155 51 38 13 
d 90/Birth 441 230 211 20 11 9 
d 135/Birth 365 160 205 42 16 26 
1 Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet. 
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30 
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was 
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes 
allowed to undergo parturition. 
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Table 3. Number of metabolites in major pathways altered by treatment. 
Major Metabolic 
Pathway 
Total Number of 
Metabolites in Pathway 
Pathway Metabolites 
Altered in OVER vs. 
CON 
Pathway Metabolites 
Altered in RES vs. 
CON 
Amino Acid  161 63 53 
Peptide 17 6 4 
Carbohydrate 39 12 8 
Energy 11 1 1 
Lipid 268 70 89 
Nucleotide 56 10 16 
Cofactors and Vitamins 31 15 12 
Xenobiotics  29 10 13 
1 Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet. 
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30 
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was 
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes 
allowed to undergo parturition. 
2Significance is determined at P ≤ 0.05 compared with CON. Total number of metabolites is 
determined from combining d 90, d 135, and birth time-points.    
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Figure 5: Principle Component Analysis (PCA) and hierarchical clustering obtained from 
employing metabolic concentration of all metabolites detected in LD tissue. PCA of LD 
samples indicates that time is the primary driver of variance between samples. LD samples (n = 8 
per treatment per time point) were collected from offspring born to ewes fed CON, RES, or 
OVER diets at d 90, 135 of gestation, or within 24 hours of birth were analyzed by UPLC-
MS/MS.  
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Table 4: Pathways altered by treatment across time.  
 
Pathway Name 
Pathway Metabolites  
Enrichment 1 
(k/m)/(n/N) 
Significant 
(k) 
Detected 
(m) 
Significant/ 
Detected 
(k/m) 
Acetylated Peptides 1 1 1 5.37 
Bacterial/Fungal 1 1 1 5.37 
Ketone Bodies 1 1 1 5.37 
Riboflavin Metabolism 2 2 1 5.37 
Tocopherol Metabolism 1 1 1 5.37 
Vitamin A Metabolism 1 1 1 5.37 
Medium Chain Fatty Acid 3 5 0.6 3.22 
Fatty Acid Metabolism (also BCAA Metabolism) 1 2 0.5 2.68 
Pentose Phosphate Pathway 1 2 0.5 2.68 
Primary Bile Acid Metabolism 3 6 0.5 2.68 
Pyrimidine Metabolism, Thymine containing 1 2 0.5 2.68 
Vitamin B6 Metabolism 1 2 0.5 2.68 
Sphingolipid Metabolism 15 31 0.48 2.6 
Lysophospholipid 11 24 0.46 2.46 
Phosphatidylethanolamine  5 11 0.45 2.44 
Histidine Metabolism 6 14 0.43 2.3 
Chemical 2 5 0.4 2.15 
Hemoglobin and Porphyrin Metabolism 2 5 0.4 2.15 
Nucleotide Sugar 2 5 0.4 2.15 
Urea cycle; Arginine and Proline Metabolism 6 16 0.38 2.01 
Pantothenate and CoA Metabolism 1 3 0.33 1.79 
Benzoate Metabolism 3 10 0.3 1.61 
Glutathione Metabolism 3 10 0.3 1.61 
Nicotinate and Nicotinamide Metabolism 3 10 0.3 1.61 
Plasmalogen 3 10 0.3 1.61 
Methionine, Cysteine, SAM and Taurine Metabolism 5 17 0.29 1.58 
Glycine, Serine and Threonine Metabolism 3 11 0.27 1.46 
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Alanine and Aspartate Metabolism 2 8 0.25 1.34 
Food Component/Plant 3 13 0.23 1.24 
Gamma-glutamyl Amino Acid 3 13 0.23 1.24 
Glutamate Metabolism 3 13 0.23 1.24 
Fatty Acid, Dicarboxylate 2 9 0.22 1.19 
Lysoplasmalogen 1 5 0.2 1.07 
Phosphatidylcholine  3 17 0.18 0.95 
Lysine Metabolism 2 12 0.17 0.89 
Fructose, Mannose and Galactose Metabolism 1 7 0.14 0.77 
Tyrosine Metabolism 1 7 0.14 0.77 
Purine Metabolism, (Hypo) Xanthine/Inosine containing 1 11 0.09 0.49 
Tryptophan Metabolism 1 11 0.09 0.49 
Leucine, Isoleucine and Valine Metabolism 2 24 0.08 0.45 
Pyrimidine Metabolism, Uracil containing 1 12 0.08 0.45 
Fatty Acid Metabolism (Acyl Carnitine) 1 34 0.03 0.16 
1 All compounds; Significant (n) = 114, Detected (N) = 612, Significant/ detected (n/N) = 0.19 
2 Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet. 
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30 
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was 
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes 
allowed to undergo parturition. 
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Table 5: Pathways altered by treatment. 
 
Pathway Name 
Pathway Metabolites  
Enrichment 1 
(k/m)/(n/N) 
Significant 
(k) 
Detected 
(m) 
Significant/ 
Detected 
(k/m) 
Acetylated Peptides 1 1 1 4.6 
Advanced Glycation End-product 1 1 1 4.6 
Bacterial/Fungal 1 1 1 4.6 
Phosphatidylglycerol  1 1 1 4.6 
Thiamine Metabolism 2 2 1 4.6 
Phosphatidylethanolamine  7 11 0.64 2.93 
Carnitine Metabolism 1 2 0.5 2.3 
Guanidino and Acetamido Metabolism 1 2 0.5 2.3 
Histidine Metabolism 7 14 0.5 2.3 
Primary Bile Acid Metabolism 3 6 0.5 2.3 
Pyrimidine Metabolism, Orotate containing 1 2 0.5 2.3 
Secondary Bile Acid Metabolism 2 4 0.5 2.3 
Methionine, Cysteine, SAM and Taurine Metabolism 8 17 0.47 2.17 
Phosphatidylcholine  8 17 0.47 2.17 
Food Component/Plant 6 13 0.46 2.12 
Glutamate Metabolism 6 13 0.46 2.12 
Aminosugar Metabolism 3 7 0.43 1.97 
Tyrosine Metabolism 3 7 0.43 1.97 
Lysophospholipid 10 24 0.42 1.92 
Hemoglobin and Porphyrin Metabolism 2 5 0.4 1.84 
Lysoplasmalogen 2 5 0.4 1.84 
Glycine, Serine and Threonine Metabolism 4 11 0.36 1.67 
Dipeptide 1 3 0.33 1.53 
Inositol Metabolism 1 3 0.33 1.53 
Phenylalanine Metabolism 1 3 0.33 1.53 
Benzoate Metabolism 3 10 0.3 1.38 
Nicotinate and Nicotinamide Metabolism 3 10 0.3 1.38 
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Plasmalogen 3 10 0.3 1.38 
Purine Metabolism, (Hypo) Xanthine/Inosine 
containing 
3 11 0.27 1.25 
Alanine and Aspartate Metabolism 2 8 0.25 1.15 
Polyunsaturated Fatty Acid (n3 and n6) 3 12 0.25 1.15 
Gamma-glutamyl Amino Acid 3 13 0.23 1.06 
Polyamine Metabolism 2 9 0.22 1.02 
Ascorbate and Aldarate Metabolism 1 5 0.2 0.92 
Chemical 1 5 0.2 0.92 
Endocannabinoid 1 5 0.2 0.92 
Medium Chain Fatty Acid 1 5 0.2 0.92 
Phospholipid Metabolism 2 10 0.2 0.92 
Urea cycle; Arginine and Proline Metabolism 3 16 0.19 0.86 
Tryptophan Metabolism 2 11 0.18 0.84 
Leucine, Isoleucine and Valine Metabolism 4 24 0.17 0.77 
Fructose, Mannose and Galactose Metabolism 1 7 0.14 0.66 
Progestin Steroids 1 7 0.14 0.66 
Fatty Acid, Dicarboxylate 1 9 0.11 0.51 
Ceramides 1 10 0.1 0.46 
Glutathione Metabolism 1 10 0.1 0.46 
Pyrimidine Metabolism, Cytidine containing 1 10 0.1 0.46 
Sphingolipid Metabolism 3 31 0.1 0.45 
Purine Metabolism, Adenine containing 1 11 0.09 0.42 
Lysine Metabolism 1 12 0.08 0.38 
Fatty Acid Metabolism (Acyl Carnitine) 2 34 0.06 0.27 
1 All compounds; Significant (n) = 133, Detected (N) = 612, Significant/ detected (n/N) = 0.22 
2 Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet. 
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30 
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was 
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes 
allowed to undergo parturition. 
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Table 6: Pathways altered by time. 
 
Pathway Name 
Pathway Metabolites  
Enrichment 1 
(k/m)/(n/N) 
Significant 
(k) 
Detected 
(m) 
Significant/ 
Detected 
(k/m) 
Acetylated Peptides 1 1 1 1.07 
Advanced Glycation End-product 1 1 1 1.07 
Alanine and Aspartate Metabolism 8 8 1 1.07 
Aminosugar Metabolism 7 7 1 1.07 
Ascorbate and Aldarate Metabolism 5 5 1 1.07 
Bacterial/Fungal 1 1 1 1.07 
Carnitine Metabolism 2 2 1 1.07 
Ceramides 10 10 1 1.07 
Chemical 5 5 1 1.07 
Corticosteroids 1 1 1 1.07 
Creatine Metabolism 4 4 1 1.07 
Diacylglycerol 9 9 1 1.07 
Dipeptide 3 3 1 1.07 
Endocannabinoid 5 5 1 1.07 
Fatty Acid Metabolism 1 1 1 1.07 
Fatty Acid Metabolism (Acyl Choline) 1 1 1 1.07 
Fatty Acid Metabolism (also BCAA Metabolism) 2 2 1 1.07 
Fatty Acid Metabolism (Acyl Carnitine) 34 34 1 1.07 
Fatty Acid Metabolism (Acyl Glycine) 2 2 1 1.07 
Fatty Acid Synthesis 2 2 1 1.07 
Fatty Acid, Amino 1 1 1 1.07 
Fatty Acid, Branched 2 2 1 1.07 
Fatty Acid, Monohydroxy 5 5 1 1.07 
Food Component/Plant 13 13 1 1.07 
Gamma-glutamyl Amino Acid 13 13 1 1.07 
Glutamate Metabolism 13 13 1 1.07 
Glycerolipid Metabolism 3 3 1 1.07 
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Glycine, Serine and Threonine Metabolism 11 11 1 1.07 
Guanidino and Acetamido Metabolism 2 2 1 1.07 
Hemoglobin and Porphyrin Metabolism 5 5 1 1.07 
Inositol Metabolism 3 3 1 1.07 
Ketone Bodies 1 1 1 1.07 
Medium Chain Fatty Acid 5 5 1 1.07 
Mevalonate Metabolism 1 1 1 1.07 
Monoacylglycerol 9 9 1 1.07 
Nicotinate and Nicotinamide Metabolism 10 10 1 1.07 
Pantothenate and CoA Metabolism 3 3 1 1.07 
Phenylalanine Metabolism 3 3 1 1.07 
Phosphatidylethanolamine  11 11 1 1.07 
Phosphatidylglycerol  1 1 1 1.07 
Phosphatidylinositol  2 2 1 1.07 
Phosphatidylserine 3 3 1 1.07 
Polyamine Metabolism 9 9 1 1.07 
Polyunsaturated Fatty Acid (n3 and n6) 12 12 1 1.07 
Pregnenolone Steroids 3 3 1 1.07 
Progestin Steroids 7 7 1 1.07 
Purine and Pyrimidine Metabolism 1 1 1 1.07 
Purine Metabolism, Guanine containing 7 7 1 1.07 
Pyrimidine Metabolism, Orotate containing 2 2 1 1.07 
Pyrimidine Metabolism, Thymine containing 2 2 1 1.07 
Pyrimidine Metabolism, Uracil containing 12 12 1 1.07 
Riboflavin Metabolism 2 2 1 1.07 
TCA Cycle 9 9 1 1.07 
Thiamine Metabolism 2 2 1 1.07 
Tocopherol Metabolism 1 1 1 1.07 
Tyrosine Metabolism 7 7 1 1.07 
Vitamin A Metabolism 1 1 1 1.07 
Vitamin B6 Metabolism 2 2 1 1.07 
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Leucine, Isoleucine and Valine Metabolism 23 24 0.96 1.02 
Lysophospholipid 23 24 0.96 1.02 
Methionine, Cysteine, SAM and Taurine Metabolism 16 17 0.94 1 
Phosphatidylcholine  16 17 0.94 1 
Urea cycle; Arginine and Proline Metabolism 15 16 0.94 1 
Histidine Metabolism 13 14 0.93 0.99 
Lysine Metabolism 11 12 0.92 0.98 
Glycolysis, Gluconeogenesis, and Pyruvate Metabolism 10 11 0.91 0.97 
Purine Metabolism, (Hypo) Xanthine/Inosine containing 10 11 0.91 0.97 
Purine Metabolism, Adenine containing 10 11 0.91 0.97 
Sphingolipid Metabolism 28 31 0.9 0.96 
Benzoate Metabolism 9 10 0.9 0.96 
Phospholipid Metabolism 9 10 0.9 0.96 
Plasmalogen 9 10 0.9 0.96 
Pyrimidine Metabolism, Cytidine containing 9 10 0.9 0.96 
Fatty Acid, Dicarboxylate 8 9 0.89 0.95 
Long Chain Fatty Acid 10 12 0.83 0.89 
Pentose Metabolism 5 6 0.83 0.89 
Glutathione Metabolism 8 10 0.8 0.85 
Lysoplasmalogen 4 5 0.8 0.85 
Nucleotide Sugar 4 5 0.8 0.85 
Secondary Bile Acid Metabolism 3 4 0.75 0.8 
Tryptophan Metabolism 8 11 0.73 0.78 
Fructose, Mannose and Galactose Metabolism 5 7 0.71 0.76 
Oxidative Phosphorylation 1 2 0.5 0.53 
Pentose Phosphate Pathway 1 2 0.5 0.53 
Primary Bile Acid Metabolism 3 6 0.5 0.53 
1 All compounds; Significant (n) = 574, Detected (N) = 612, Significant/ detected (n/N) = 0.94 
2 Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet. 
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30 
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was 
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performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes 
allowed to undergo parturition. 
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Table 7: Pathways altered at d 90 in RES compared with CON.  
 
Pathway Name 
Pathway Metabolites  
Enrichment 1 
(k/m)/(n/N) 
Significant 
(k) 
Detected 
(m) 
Significant/ 
Detected 
(k/m) 
Advanced Glycation End-product 1 1 1 7.12 
Ceramides 7 10 0.7 4.98 
Sphingolipid Metabolism 16 31 0.52 3.67 
Plasmalogen 5 10 0.5 3.56 
Thiamine Metabolism 1 2 0.5 3.56 
Nucleotide Sugar 2 5 0.4 2.85 
Food Component/Plant 5 13 0.38 2.74 
Phosphatidylethanolamine  4 11 0.36 2.59 
Inositol Metabolism 1 3 0.33 2.37 
Pantothenate and CoA Metabolism 1 3 0.33 2.37 
Primary Bile Acid Metabolism 2 6 0.33 2.37 
Benzoate Metabolism 3 10 0.3 2.13 
Nicotinate and Nicotinamide Metabolism 3 10 0.3 2.13 
Pyrimidine Metabolism, Cytidine containing 3 10 0.3 2.13 
Phosphatidylcholine  5 17 0.29 2.09 
Glutathione Metabolism 2 10 0.2 1.42 
Lysoplasmalogen 1 5 0.2 1.42 
Medium Chain Fatty Acid 1 5 0.2 1.42 
Pyrimidine Metabolism, Uracil containing 2 12 0.17 1.19 
Glutamate Metabolism 2 13 0.15 1.09 
Tyrosine Metabolism 1 7 0.14 1.02 
Alanine and Aspartate Metabolism 1 8 0.12 0.89 
Lysophospholipid 3 24 0.12 0.89 
Methionine, Cysteine, SAM and Taurine Metabolism 2 17 0.12 0.84 
Fatty Acid, Dicarboxylate 1 9 0.11 0.79 
Polyamine Metabolism 1 9 0.11 0.79 
Glycine, Serine and Threonine Metabolism 1 11 0.09 0.65 
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Tryptophan Metabolism 1 11 0.09 0.65 
Fatty Acid Metabolism (Acyl Carnitine) 3 34 0.09 0.63 
Leucine, Isoleucine and Valine Metabolism 2 24 0.08 0.59 
Lysine Metabolism 1 12 0.08 0.59 
Polyunsaturated Fatty Acid (n3 and n6) 1 12 0.08 0.59 
Urea cycle; Arginine and Proline Metabolism 1 16 0.06 0.44 
1 All compounds; Significant (n) = 86, Detected (N) = 612, Significant/ detected (n/N) = 0.14 
2 Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet. 
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30 
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was 
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes 
allowed to undergo parturition. 
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Table 8: Pathways altered at d 135 in RES compared with CON. 
 
Pathway Name 
Pathway Metabolites  
Enrichment 1 
(k/m)/(n/N) 
Significant 
(k) 
Detected 
(m) 
Significant/ 
Detected 
(k/m) 
Bacterial/Fungal 1 1 1 8.5 
Ketone Bodies 1 1 1 8.5 
Phosphatidylglycerol  1 1 1 8.5 
Riboflavin Metabolism 2 2 1 8.5 
Histidine Metabolism 7 14 0.5 4.25 
Pyrimidine Metabolism, Thymine containing 1 2 0.5 4.25 
Secondary Bile Acid Metabolism 2 4 0.5 4.25 
Hemoglobin and Porphyrin Metabolism 2 5 0.4 3.4 
Glycerolipid Metabolism 1 3 0.33 2.83 
Gamma-glutamyl Amino Acid 4 13 0.31 2.62 
Tyrosine Metabolism 2 7 0.29 2.43 
Glycine, Serine and Threonine Metabolism 3 11 0.27 2.32 
Alanine and Aspartate Metabolism 2 8 0.25 2.13 
Lysophospholipid 6 24 0.25 2.13 
Methionine, Cysteine, SAM and Taurine Metabolism 4 17 0.24 2 
Fatty Acid, Dicarboxylate 2 9 0.22 1.89 
Polyamine Metabolism 2 9 0.22 1.89 
Chemical 1 5 0.2 1.7 
Glutathione Metabolism 2 10 0.2 1.7 
Lysoplasmalogen 1 5 0.2 1.7 
Phospholipid Metabolism 2 10 0.2 1.7 
Urea cycle; Arginine and Proline Metabolism 3 16 0.19 1.59 
Primary Bile Acid Metabolism 1 6 0.17 1.42 
Food Component/Plant 2 13 0.15 1.31 
Aminosugar Metabolism 1 7 0.14 1.21 
Progestin Steroids 1 7 0.14 1.21 
Phosphatidylcholine  2 17 0.12 1 
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TCA Cycle 1 9 0.11 0.94 
Benzoate Metabolism 1 10 0.1 0.85 
Plasmalogen 1 10 0.1 0.85 
Glycolysis, Gluconeogenesis, and Pyruvate 
Metabolism 
1 11 0.09 0.77 
Purine Metabolism, (Hypo) Xanthine/Inosine 
containing 
1 11 0.09 0.77 
Tryptophan Metabolism 1 11 0.09 0.77 
Lysine Metabolism 1 12 0.08 0.71 
Polyunsaturated Fatty Acid (n3 and n6) 1 12 0.08 0.71 
Pyrimidine Metabolism, Uracil containing 1 12 0.08 0.71 
Glutamate Metabolism 1 13 0.08 0.65 
Sphingolipid Metabolism 2 31 0.06 0.55 
Leucine, Isoleucine and Valine Metabolism 1 24 0.04 0.35 
1 All compounds; Significant (n) = 72, Detected (N) = 612, Significant/ detected (n/N) = 0.12 
2 Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet. 
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30 
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was 
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes 
allowed to undergo parturition. 
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Table 9: Pathways altered at birth in RES compared with CON. 
 
Pathway Name 
Pathway Metabolites  
Enrichment 1 
(k/m)/(n/N) 
Significant 
(k) 
Detected 
(m) 
Significant/ 
Detected 
(k/m) 
Phosphatidylglycerol  1 1 1 9.56 
Purine and Pyrimidine Metabolism 1 1 1 9.56 
Tocopherol Metabolism 1 1 1 9.56 
Phenylalanine Metabolism 2 3 0.67 6.37 
Nucleotide Sugar 3 5 0.6 5.74 
Guanidino and Acetamido Metabolism 1 2 0.5 4.78 
Pyrimidine Metabolism, Orotate containing 1 2 0.5 4.78 
Thiamine Metabolism 1 2 0.5 4.78 
Lysophospholipid 10 24 0.42 3.98 
Alanine and Aspartate Metabolism 3 8 0.38 3.59 
Histidine Metabolism 4 14 0.29 2.73 
Progestin Steroids 2 7 0.29 2.73 
Secondary Bile Acid Metabolism 1 4 0.25 2.39 
Phosphatidylcholine  4 17 0.24 2.25 
Food Component/Plant 3 13 0.23 2.21 
Lysoplasmalogen 1 5 0.2 1.91 
Nicotinate and Nicotinamide Metabolism 2 10 0.2 1.91 
Pyrimidine Metabolism, Cytidine containing 2 10 0.2 1.91 
Primary Bile Acid Metabolism 1 6 0.17 1.59 
Pyrimidine Metabolism, Uracil containing 2 12 0.17 1.59 
Glutamate Metabolism 2 13 0.15 1.47 
Fructose, Mannose and Galactose Metabolism 1 7 0.14 1.37 
Urea cycle; Arginine and Proline Metabolism 2 16 0.12 1.2 
Methionine, Cysteine, SAM and Taurine Metabolism 2 17 0.12 1.12 
Fatty Acid, Dicarboxylate 1 9 0.11 1.06 
Monoacylglycerol 1 9 0.11 1.06 
Phosphatidylethanolamine  1 11 0.09 0.87 
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Purine Metabolism, (Hypo) Xanthine/Inosine containing 1 11 0.09 0.87 
Purine Metabolism, Adenine containing 1 11 0.09 0.87 
Tryptophan Metabolism 1 11 0.09 0.87 
Fatty Acid Metabolism (Acyl Carnitine) 3 34 0.09 0.84 
Sphingolipid Metabolism 2 31 0.06 0.62 
1 All compounds; Significant (n) = 64, Detected (N) = 612, Significant/ detected (n/N) = 0.10 
2 Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet. 
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30 
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was 
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes 
allowed to undergo parturition. 
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Table 10: Pathways altered at d 90 in OVER compared with CON. 
 
Pathway Name 
Pathway Metabolites  
Enrichment 1 
(k/m)/(n/N) 
Significant 
(k) 
Detected 
(m) 
Significant/ 
Detected 
(k/m) 
Acetylated Peptides 1 1 1 7.85 
Fatty Acid, Amino 1 1 1 7.85 
Pyrimidine Metabolism, Thymine containing 2 2 1 7.85 
Pantothenate and CoA Metabolism 2 3 0.67 5.23 
Nucleotide Sugar 3 5 0.6 4.71 
Tyrosine Metabolism 4 7 0.57 4.48 
Pentose Phosphate Pathway 1 2 0.5 3.92 
Riboflavin Metabolism 1 2 0.5 3.92 
Thiamine Metabolism 1 2 0.5 3.92 
Vitamin B6 Metabolism 1 2 0.5 3.92 
Alanine and Aspartate Metabolism 3 8 0.38 2.94 
Dipeptide 1 3 0.33 2.62 
Primary Bile Acid Metabolism 2 6 0.33 2.62 
Glutathione Metabolism 3 10 0.3 2.35 
Histidine Metabolism 4 14 0.29 2.24 
Glycine, Serine and Threonine Metabolism 3 11 0.27 2.14 
Purine Metabolism, Adenine containing 3 11 0.27 2.14 
Tryptophan Metabolism 3 11 0.27 2.14 
Secondary Bile Acid Metabolism 1 4 0.25 1.96 
Food Component/Plant 3 13 0.23 1.81 
Gamma-glutamyl Amino Acid 3 13 0.23 1.81 
Glutamate Metabolism 3 13 0.23 1.81 
Leucine, Isoleucine and Valine Metabolism 5 24 0.21 1.63 
Ascorbate and Aldarate Metabolism 1 5 0.2 1.57 
Chemical 1 5 0.2 1.57 
Hemoglobin and Porphyrin Metabolism 1 5 0.2 1.57 
Urea cycle; Arginine and Proline Metabolism 3 16 0.19 1.47 
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Glycolysis, Gluconeogenesis, and Pyruvate Metabolism 2 11 0.18 1.43 
Long Chain Fatty Acid 2 12 0.17 1.31 
Fructose, Mannose and Galactose Metabolism 1 7 0.14 1.12 
Methionine, Cysteine, SAM and Taurine Metabolism 2 17 0.12 0.92 
TCA Cycle 1 9 0.11 0.87 
Benzoate Metabolism 1 10 0.1 0.78 
Nicotinate and Nicotinamide Metabolism 1 10 0.1 0.78 
Purine Metabolism, (Hypo) Xanthine/Inosine containing 1 11 0.09 0.71 
Lysine Metabolism 1 12 0.08 0.65 
Lysophospholipid 2 24 0.08 0.65 
Pyrimidine Metabolism, Uracil containing 1 12 0.08 0.65 
Sphingolipid Metabolism 2 31 0.06 0.51 
Phosphatidylcholine  1 17 0.06 0.46 
1 All compounds; Significant (n) = 78, Detected (N) = 612, Significant/ detected (n/N) = 0.13 
2 Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet. 
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30 
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was 
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes 
allowed to undergo parturition. 
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Table 11: Pathways altered at d 135 in OVER compared with CON. 
 
Pathway Name 
Pathway Metabolites  
Enrichment 
1 (k/m)/(n/N) 
Significant 
(k) 
Detected 
(m) 
Significant/ 
Detected 
(k/m) 
Bacterial/Fungal 1 1 1 22.67 
Pyrimidine Metabolism, Orotate containing 1 2 0.5 11.33 
Fatty Acid, Dicarboxylate 2 9 0.22 5.04 
Endocannabinoid 1 5 0.2 4.53 
Hemoglobin and Porphyrin Metabolism 1 5 0.2 4.53 
Lysoplasmalogen 1 5 0.2 4.53 
Nicotinate and Nicotinamide Metabolism 2 10 0.2 4.53 
Methionine, Cysteine, SAM and Taurine Metabolism 3 17 0.18 4 
Histidine Metabolism 2 14 0.14 3.24 
Tyrosine Metabolism 1 7 0.14 3.24 
Alanine and Aspartate Metabolism 1 8 0.12 2.83 
Leucine, Isoleucine and Valine Metabolism 3 24 0.12 2.83 
Phosphatidylcholine  2 17 0.12 2.67 
Benzoate Metabolism 1 10 0.1 2.27 
Glutathione Metabolism 1 10 0.1 2.27 
Phosphatidylethanolamine  1 11 0.09 2.06 
Tryptophan Metabolism 1 11 0.09 2.06 
Food Component/Plant 1 13 0.08 1.74 
Urea cycle; Arginine and Proline Metabolism 1 16 0.06 1.42 
1 All compounds; Significant (n) = 27, Detected (N) = 612, Significant/ detected (n/N) = 0.04 
2 Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet. 
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30 
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was 
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes 
allowed to undergo parturition. 
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Table 12: Pathways altered at birth in OVER compared with CON. 
 
Pathway Name 
Pathway Compounds  
Enrichment 1 
(k/m)/(n/N) 
Significant 
(k) 
Detected 
(m) 
Significant/ 
Detected 
(k/m) 
Acetylated Peptides 1 1 1 6 
Advanced Glycation End-product 1 1 1 6 
Fatty Acid Metabolism (Acyl Choline) 1 1 1 6 
Phosphatidylglycerol  1 1 1 6 
Riboflavin Metabolism 2 2 1 6 
Tocopherol Metabolism 1 1 1 6 
Vitamin A Metabolism 1 1 1 6 
Phosphatidylethanolamine  10 11 0.91 5.45 
Alanine and Aspartate Metabolism 6 8 0.75 4.5 
Inositol Metabolism 2 3 0.67 4 
Lysophospholipid 13 24 0.54 3.25 
Fatty Acid Metabolism (also BCAA Metabolism) 1 2 0.5 3 
Phosphatidylinositol 1 2 0.5 3 
Polyamine Metabolism 4 9 0.44 2.67 
Lysoplasmalogen 2 5 0.4 2.4 
Phenylalanine Metabolism 1 3 0.33 2 
Fatty Acid Metabolism (Acyl Carnitine) 11 34 0.32 1.94 
Aminosugar Metabolism 2 7 0.29 1.71 
Glycine, Serine and Threonine Metabolism 3 11 0.27 1.64 
Methionine, Cysteine, SAM and Taurine Metabolism 4 17 0.24 1.41 
Phosphatidylcholine  4 17 0.24 1.41 
Chemical 1 5 0.2 1.2 
Hemoglobin and Porphyrin Metabolism 1 5 0.2 1.2 
Medium Chain Fatty Acid 1 5 0.2 1.2 
Nucleotide Sugar 1 5 0.2 1.2 
Plasmalogen 2 10 0.2 1.2 
Urea cycle; Arginine and Proline Metabolism 3 16 0.19 1.12 
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Tryptophan Metabolism 2 11 0.18 1.09 
Lysine Metabolism 2 12 0.17 1 
Gamma-glutamyl Amino Acid 2 13 0.15 0.92 
Fatty Acid, Dicarboxylate 1 9 0.11 0.67 
Benzoate Metabolism 1 10 0.1 0.6 
Ceramides 1 10 0.1 0.6 
Glutathione Metabolism 1 10 0.1 0.6 
Phospholipid Metabolism 1 10 0.1 0.6 
Sphingolipid Metabolism 3 31 0.1 0.58 
Glycolysis, Gluconeogenesis, and Pyruvate Metabolism 1 11 0.09 0.55 
Purine Metabolism, (Hypo)Xanthine/Inosine containing 1 11 0.09 0.55 
Polyunsaturated Fatty Acid (n3 and n6) 1 12 0.08 0.5 
Pyrimidine Metabolism, Uracil containing 1 12 0.08 0.5 
Food Component/Plant 1 13 0.08 0.46 
Glutamate Metabolism 1 13 0.08 0.46 
Histidine Metabolism 1 14 0.07 0.43 
1 All compounds; Significant (n) = 102, Detected (N) = 612, Significant/ detected (n/N) = 0.17 
2 Offspring from ewes fed a CON (100% NRC), RES (60% NRC), or OVER (140% NRC) diet. 
Ewe diet was based on the NRC requirement for pregnant ewes bearing twins and began at d 30 
of gestation. At d 90 or 135 of gestation, ewes were euthanized and a hysterectomy was 
performed to acquire LD samples. Lamb LD was collected within 24 h of birth from ewes 
allowed to undergo parturition. 
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Figure 6: Over-feeding during gestation increased offspring advanced glycation end 
products at birth. Offspring metabolites from advanced glycation end products were altered in 
OVER compared with CON. LD collected from offspring born to ewes fed CON, RES, or OVER 
diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was analyzed by UPLC-
MS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 0.05 compared with 
CON.    
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Figure 7: Over-feeding during gestation alters offspring alanine and aspartate metabolism 
at multiple time points of gestation. Offspring metabolites involved in alanine and aspartate 
metabolism were altered in OVER compared with CON. LD collected from offspring born to 
ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth 
(C) was analyzed by UPLC-MS/MS. Data are presented as fold change ± standard error. * 
denotes P ≤ 0.05 compared with CON.   
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Figure 8: Over-feeding during gestation alters offspring glutathione metabolism at multiple 
time points of gestation. Offspring metabolites involved in glutathione metabolism were altered 
in OVER compared with CON. LD collected from offspring born to ewes fed CON, RES, or 
OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was analyzed by 
UPLC-MS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 0.05 compared 
with CON.  
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Figure 9: Over-feeding during gestation alters offspring histidine metabolism at multiple 
time points of gestation. Offspring metabolites involved histidine metabolism were altered in 
OVER compared with CON. LD collected from offspring born to ewes fed CON, RES, or OVER 
diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was analyzed by UPLC-
MS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 0.05 compared with 
CON.   
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Figure 10: Over-feeding during gestation alters offspring leucine, isoleucine, and valine 
metabolism at multiple time points of gestation. Offspring metabolites involved in leucine, 
isoleucine, and valine metabolism were altered in OVER compared with CON. LD collected 
from offspring born to ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or 
within 24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are presented as fold change 
± standard error. * denotes P ≤ 0.05 compared with CON.   
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Figure 11: Over-feeding during gestation alters offspring tryptophan metabolism at 
multiple time points of gestation. Offspring metabolites involved in tryptophan metabolism 
were altered in OVER compared with CON. LD collected from offspring born to ewes fed CON, 
RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was 
analyzed by UPLC-MS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 
0.05 compared with CON.   
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Figure 12: Over-feeding during gestation alters offspring tyrosine metabolism at multiple 
time points of gestation. Offspring metabolites involved in tyrosine metabolism were altered in 
OVER compared with CON. LD collected from offspring born to ewes fed CON, RES, or OVER 
diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was analyzed by UPLC-
MS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 0.05 compared with 
CON.   
78 
 
 
 
Figure 13: Over-feeding during gestation alters offspring fatty acid and branched chain 
amino acid metabolism at birth. Offspring metabolites involved in fatty acid and branched 
chain amino acid metabolism were altered in OVER compared with CON. LD collected from 
offspring born to ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 
24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are presented as fold change ± 
standard error. * denotes P ≤ 0.05 compared with CON.   
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Figure 14: Over-feeding during gestation alters offspring fatty acid and acyl carnitine 
metabolism at birth. Offspring metabolites involved in fatty acid and acyl carnitine metabolism 
were altered in OVER compared with CON. LD collected from offspring born to ewes fed CON, 
RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was 
analyzed by UPLC-MS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 
0.05 compared with CON. 
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Figure 15: Over-feeding during gestation alters offspring lysophospholipid metabolism at 
multiple time points of gestation. Offspring metabolites involved in lysophospholipid 
metabolism were altered in OVER compared with CON. LD collected from offspring born to 
ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth 
(C) was analyzed by UPLC-MS/MS. Data are presented as fold change ± standard error. * 
denotes P ≤ 0.05 compared with CON.   
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Figure 16: Over-feeding during gestation alters offspring phosphatidylethanolamine 
metabolism at multiple time points of gestation. Offspring metabolites involved in 
phosphatidylethanolamine metabolism were altered in OVER compared with CON. LD collected 
from offspring born to ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or 
within 24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are presented as fold change 
± standard error. * denotes P ≤ 0.05 compared with CON.    
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Figure 17: Restricted-feeding during gestation alters offspring glutamate metabolism at 
multiple time points of gestation. Offspring metabolites involved in glutamate metabolism 
were altered in RES compared with CON. LD collected from offspring born to ewes fed CON, 
RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was 
analyzed by UPLC-MS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 
0.05 compared with CON.   
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Figure 18: Restricted-feeding during gestation alters offspring glutathione metabolism at 
multiple time points of gestation. Offspring metabolites involved in glutathione metabolism 
were altered in RES compared with CON. LD collected from offspring born to ewes fed CON, 
RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was 
analyzed by UPLC-MS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 
0.05 compared with CON.   
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Figure 19: Restricted-feeding during gestation alters offspring histidine metabolism at 
multiple time points of gestation. Offspring metabolites involved in histidine metabolism were 
altered in RES compared with CON. LD collected from offspring born to ewes fed CON, RES, 
or OVER diets at d 90 (A), 135 (B) of gestation, or within 24 hours of birth (C) was analyzed by 
UPLC-MS/MS. Data are presented as fold change ± standard error. * denotes P ≤ 0.05 compared 
with CON.  
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Figure 20: Restricted-feeding during gestation alters offspring lysophospholipid 
metabolism at multiple time points of gestation. Offspring metabolites involved in 
lysophospholipid metabolism were altered in RES compared with CON. LD collected from 
offspring born to ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 
24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are presented as fold change ± 
standard error. * denotes P ≤ 0.05 compared with CON.   
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Figure 21: Restricted-feeding during gestation alters offspring phosphatidylcholine 
metabolism at multiple time points of gestation. Offspring metabolites involved in 
phosphatidylcholine metabolism were altered in RES compared with CON. LD collected from 
offspring born to ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or within 
24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are presented as fold change ± 
standard error. * denotes P ≤ 0.05 compared with CON.   
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Figure 22: Restricted-feeding during gestation alters offspring phosphatidylethanolamine 
metabolism at multiple time points of gestation. Offspring metabolites involved in 
phosphatidylethanolamine metabolism were altered in RES compared with CON. LD collected 
from offspring born to ewes fed CON, RES, or OVER diets at d 90 (A), 135 (B) of gestation, or 
within 24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are presented as fold change. 
* denotes P ≤ 0.05 compared with CON.  
88 
 
 
89 
 
 
Figure 23: Restricted-feeding during gestation alters offspring sphingolipid metabolism at 
birth. Offspring metabolites involved in sphingolipid metabolism were altered in RES compared 
with CON. LD collected from offspring born to ewes fed CON, RES, or OVER diets at d 90 (A), 
135 (B) of gestation, or within 24 hours of birth (C) was analyzed by UPLC-MS/MS. Data are 
presented as fold change ± standard error. * denotes P ≤ 0.05 compared with CON.   
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DISCUSSION 
 
When assessing the effects of poor maternal nutrition during gestation on offspring 
development, many research groups focus on either restricted- (Vonnahme et al., 2003; Daniel et 
al., 2007; Ford et al., 2007; Ge et al., 2013) or over-feeding (Zhu et al., 2008; Tong et al., 2009; 
Caton et al., 2009; Long et al., 2010; Yan et al., 2011). Our model is unique since it allows for 
comparison of both restricted- and over-nutrition at multiple time points during gestation (Pillai 
et al., 2017). Additionally, the multiple prenatal and birth time points allow us to assess changes 
to offspring development and metabolism over time. Restricted- and over-feeding can result in 
similar phenotypic changes to the offspring, such as changes in CSA of muscle fibers (Reed et 
al., 2014). However, the mechanisms behind these changes are often different, due to the 
influence of the maternal diet (Hoffman et al., 2016). One mechanism that can promote these 
changes is alterations to offspring metabolism (Hoffman et al., 2017). Previous studies have 
determined that metabolism is a key factor that determines if a cell will proliferate, differentiate, 
or remain quiescent (Ochocki and Simon, 2013; Shyh-Chang et al., 2013; Hu et al., 2016). 
Energy metabolism and nutrient sensing help regulate stem cell function and tissue development 
during gestation (Ochocki and Simon, 2013; Shyh-Chang et al., 2013; Hu et al., 2016). This is 
especially important for muscle, since gestation is a critical window of development for skeletal 
muscle formation and requires the coordinated progression of cell proliferation, cell cycle exit, 
and differentiation (Braun et al., 2011).  
Changes to the intrauterine environment and offspring metabolism in response to poor 
maternal nutrition can alter the concentrations of hormones and growth factors, ultimately 
affecting metabolism. Specifically, lambs exposed to under- and over-nutrition during gestation 
demonstrated decreased serum concentrations of IGF1 and IGF binding protein 3 at birth 
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(Hoffman et al., 2014). Further, at 3 mo of age, leptin concentrations were increased in offspring 
from over-fed ewes compared with restricted-fed ewes (Hoffman et al., 2016). In the same study, 
average insulin concentrations between birth and 3 mo of age were increased in offspring from 
over-fed and restricted-fed ewes compared with controls (Hoffman et al., 2016). Exposure to 
maternal undernutrition also altered glucose tolerance in the offspring (Ford et al., 2007). 
Specifically, at d 63 of age, lambs from restricted-fed mothers had greater area under the curve 
for glucose and insulin compared with controls. These changes to hormone and growth factor 
concentrations have the potential to influence the formation and development of muscle fibers 
during gestation (Baum et al., 1996; Sotiropoulos et al., 2006; Velloso et al., 2008).  
Circulating factors and hormone concentrations can impact muscle fiber formation and 
growth by increasing muscle mass and regulating fiber formation (Baum et al., 1996; 
Sotiropoulos et al., 2006; Velloso et al., 2008). These circulating factors may also be influencing 
the muscle phenotype by altering stem cell populations. Studies support that poor maternal 
nutrition can negatively impact offspring stem cells. In mice, exposure to both maternal under-
nutrition and early postnatal over-nutrition decreased the number of skeletal muscle precursor 
cells (Woo et al., 2011). In the absence of cultured skeletal muscle precursor cells from lambs, 
C2C12 myoblasts can be used to assess how serum from offspring exposed to poor maternal 
nutrition influences myoblast proliferation, differentiation, and metabolism. Despite evidence 
which supports changes to hormones and growth factors in offspring serum in response to poor 
maternal nutrition, serum collected at birth from offspring exposed to under- or over-nutrition 
had no effect on myoblast proliferation, fiber fusion index, or fiber diameter. Other factors such 
as genetics and epigenetics can regulate muscle development (Peñagaricano et al., 2014; Kalbe et 
al., 2017). Many experiments demonstrate that poor maternal nutrition influences gene 
92 
 
expression in muscle. For example, Kalbe et al., (2017) found that exposure to maternal 
increased and restricted protein diets altered the mRNA expression of myogenic regulatory 
factors and IGFs. Another experiment demonstrated that maternal high-starch diet induces gene 
expression changes in the skeletal muscle and adipose of lambs (Peñagaricano et al., 2014). 
Specifically, genes involved in myogenic differentiation, glycolysis, gluconeogenesis, and the 
insulin signaling pathway were differentially expressed (Peñagaricano et al., 2014). These 
alterations to gene expression in response to poor maternal nutrition may be causing changes to 
muscle development along with changes to hormone and growth factor concentrations in serum. 
Additionally, the birth time point for serum collection may be a reason that there are no changes 
to proliferation or differentiation. Many studies examine changes to hormone concentrations at 
postnatal time points when the animal is more mature (Ford et al., 2007; Hoffman et al., 2014, 
2016). Collecting serum from lambs exposed to poor maternal nutrition during gestation at later 
time points may result in different findings.  
In addition to assessing whether serum from offspring from over- and restricted-fed ewes 
could influence C2C12 proliferation and differentiation, we analyzed whether the serum could 
influence myoblast metabolism. The serum collected from offspring exposed to restricted 
maternal diet altered the mitochondrial respiration of C2C12 myoblasts. Specifically, offspring 
from restricted-fed ewes exhibited increased proton leak compared with controls. Proton 
pumping across the mitochondrial membrane and proton leak contribute to a cycle that dissipates 
redox energy (Rolfe et al., 1999). Additionally, the mitochondrial proton cycle contributes to 
15% of the standard metabolic rate in skeletal muscle (Rolfe et al., 1999). Increased proton leak 
could result in increased metabolic rate which could largely affect mitochondrial metabolism and 
potentially decrease efficiency (Rolfe et al., 1999). Multiple studies have demonstrated that. 
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caloric restriction decreases skeletal muscle proton leak (Bevilacqua et al., 2004; Bevilacqua et 
al., 2005). This is of note because our study demonstrated contrary findings since C2C12 
myoblasts cultured in serum from RES offspring had increased proton leak. However, this result 
may be different if proton leak was measured in the mitochondria or in satellite cells isolated 
from RES offspring. Others have shown that poor maternal nutrition during gestation can alter 
metabolism in other stem cells (Pillai et al., 2016). Specifically, Pillai et al., (2016) reported that 
restricted feeding decreased basal respiration, ATP production, and maximal respiration of 
offspring mesenchymal stem cells compared with controls. Additionally, maternal over-feeding 
decreased basal respiration, ATP production, maximal respiration, and spare-respiratory capacity 
of offspring mesenchymal stem cells compared with controls. Although the variables altered 
were different than in the present experiment, the data demonstrate that poor maternal nutrition 
can alter stem cell metabolism in different cell populations. In mice, male offspring from obese 
mothers had decreased mitochondrial complex II-III (Shelley et al., 2009). Another group 
showed that pigs exposed in utero to high energy diets had decreased mitochondrial DNA 
content and downregulated mRNA expression of genes associated with mitochondrial biogenesis 
and function (Zou et al., 2016a). Further, moderate maternal dietary energy intake decreased 
mitochondrial biogenesis (Zou et al., 2016b). Despite noted differences in mitochondrial 
respiration in C2C12 myoblasts exposed to offspring serum, there were no changes to glycolytic 
function. Similarly, poor maternal nutrition during gestation did not alter any of the variables 
associated with glycolytic function in mesenchymal stem cells (Pillai et al., 2016). Therefore 
poor maternal nutrition may be altering metabolism through changes to mitochondrial function.  
 
Metabolome Analysis  
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To better understand metabolic changes in muscle during gestation in response to poor 
maternal nutrition, a metabolome analysis was conducted on LM samples from offspring of 
control-fed, restricted-fed, and over-fed dams at d 90, d 135, and birth time points. Metabolome 
analysis demonstrated that both maternal diet and day of gestation drive changes to LM 
metabolism, including changes to amino acid, lipid, carbohydrate, and energy metabolism. The 
principle component analysis indicates that samples within each developmental time period (d 
90, d 135, birth) exhibit close overlapping grouping, indicative of an overall similar metabolite 
composition. This suggests that the stage of development is a more powerful driver of 
metabolism than maternal nutrition. This is not unexpected given the vast changes in fetal 
muscle metabolism during gestation. Birth represents a switch in nutrient utilization and 
metabolism (Girard, 1990; Hillman, et al., 2012). The fetal diet is rich in carbohydrates supplied 
from the mother and poor in fat. In the fetus, gluconeogenesis and ketogenesis are absent or very 
low. At birth, the maternal glucose supply is removed and the diet becomes more reliant on lipids 
and less reliant on carbohydrates (Girard, 1990). Because of this, there are drastic changes to 
energy metabolism, with gluconeogenesis and ketogenesis becoming more active within 24 h of 
birth (Girard, 1990; Hillman et al., 2012).  In our study, metabolome analysis demonstrated a 
similar shift in nutrient utilization between the fetus and postnatal animal.  
 
Maternal over-nutrition during gestation alters offspring LM metabolome at d 90 
 At d 90 of gestation, offspring from over-fed mothers exhibited altered amino acid 
metabolism compared with controls demonstrated by changes to alanine and aspartate 
metabolism, tyrosine metabolism, tryptophan metabolism, histidine metabolism, and leucine, 
isoleucine and valine metabolism. Amino acid sensing can regulate myogenesis through the 
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mammalian target of rapamycin (mTOR) pathway (Mee-Sup and Chen, 2013). The mTOR 
pathway is a key regulator of skeletal myogenesis and regulates different steps of differentiation 
(Ge and Chen, 2012). Multiple studies indicate that amino acids work upstream in the mTOR 
signaling pathway and can serve to activate signaling through the pathway, resulting in increased 
protein synthesis (Sancak et al., 2008, Ma and Blenis, 2009, Sancak et al., 2010; Bar-Peled et al., 
2012, Bar-Peled et al., 2013). Therefore, these early changes to amino acid metabolism, 
especially leucine metabolism, may play a part in regulating myogenesis.  
Offspring of over-fed dams also exhibited changes to glutathione metabolism, including 
increased reduced glutathione (GSH) and decreased cysteine-glutathione disulfide and 2-
aminobutyrate. However, the oxidized glutathione (GSSG) was similar to control. Changes to 
glutathione metabolism could be indicative of changes in redox status and oxidative stress. The 
GSH:GSSG ratio can be used as a marker of oxidative stress, and changes to this ratio are 
indicative of changes in redox status (Zitka et al., 2012). Therefore, follow up analysis of 
markers of oxidative stress and/or antioxidants in the muscle would further define the redox 
status in the offspring and the response to poor maternal nutrition.  
Maternal over-feeding also resulted in perturbations to branched-chain amino acid 
(BCAA) catabolism. Offspring from over-fed ewes exhibited divergent branched-chain amino 
acid catabolism compared with controls. Specifically, LM from offspring of over-fed mothers 
exhibited accumulation of three key intermediates of BCAA breakdown, beta-
hydroxyisovalerate, 3-methylglutaconate, and 3-hydroxyisobutyrate at both d 90 and 135 that 
indicate increased BCAA catabolism. This may reflect increased support for muscle energy 
production since the complete oxidation of the BCAAs in the mitochondria efficiently allows 
formation of ATP by oxidative phosphorylation (Brosnan and Brosnan, 2006). Less likely, 
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gluconeogenesis can also be supported, as the end-products of the pathway (succinyl CoA and 
acetyl CoA) can support both of these processes (Shimomura et al., 2004; Brosnan and Brosnan, 
2006; Tao et al., 2017). 
 
Maternal over-nutrition during gestation alters offspring LM metabolome at d 135  
Similar to d 90, the most abundant metabolite changes at d 135 were to amino acid 
metabolism, including alanine and aspartate metabolism, N-acetylaspartate (NAA) metabolism, 
branched chain amino acid metabolism, and histidine metabolism. N-acetylaspartate is 
synthesized from aspartate and acetyl-CoA by aspartate N-acetyltransferase (Bogner-Strauss, 
2017). It can then be cleaved by aspartoacylase to generate aspartate and acetate. Acetyl-CoA 
synthetase uses acetate to generate acetyl-CoA, a general energy metabolite and second 
messenger with roles in lipid synthesis (Bogner-Strauss, 2017). For histidine, imidazole 
propionate and formiminoglutamate, products of histidine catabolism, were increased compared 
with controls. There were also increases in metabolites involved in leucine, isoleucine and valine 
metabolism at d 135 compared with controls. Leucine, isoleucine, and valine are branched chain 
amino acids and are essential to muscle metabolism since they can be used as energy sources and 
are necessary for protein synthesis in the muscle (Wagenmakers et al., 1998). Branched chain 
amino acids stimulate protein synthesis and are required for mTOR regulation of myogenesis 
(Yoon et al., 2017). This pathway is essential for muscle hypertrophy and maintaining muscle 
mass (Yoon et al., 2017). At d 135, the muscle is no longer going through the primary and 
secondary waves of myogenesis, but instead starting to hypertrophy. Therefore, alterations to 
amino acid metabolism could negatively affect protein synthesis and skeletal muscle hypertrophy 
(Du et al., 2010).  
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Maternal over-nutrition during gestation alters offspring LM metabolome at birth 
Over-feeding during gestation altered the lipid metabolism in the offspring at birth. 
Specifically, increased maternal nutrient consumption induces apparent lipid oxidation in the 
lambs. There was an increase in the ketogenic marker 3-hydroxybutyrylcarnitine at birth in 
offspring from over-fed mothers. This is associated with a decrease in short and long chain 
acylcarnitines. Carnitines shuttle long-chain fatty acids into the mitochondria where they are 
used to generate ATP (McGarry et al., 1975; Parvin and Pande 1978). They serve as substrates in 
branched chain amino acid metabolism and provide readouts for β-oxidation (McGarry et al., 
1975; Parvin and Pande 1978). In general, ketogenesis increases when the rate of liver fatty acid 
β-oxidation exceeds the TCA cycles capacity to use acetyl-CoA. Ketogenesis frequently occurs 
under conditions of nutrient deprivation and high circulating free fatty acids (McGarry et al., 
1975; Parvin and Pande 1978). Thus, changes to acylcarnitines in the LM of OVER offspring 
may reflect a mechanism to utilize excess β-oxidation intermediates. Corresponding depletion of 
glycolytic intermediates dihydroxyacetone phosphate (DHAP) and phosphoenolpyruvate (PEP) 
indicate reduced carbohydrate oxidation in favor of lipid utilization. During lipid synthesis, 
DHAP provides adipose cells with the activated glycerol backbone required to synthesize new 
triglyceride. Taken together with the depletion of polyunsaturated fatty acid concentrations of 
docosapentaenoate (n3 DPA; 22:5n3) and eicosapentaenoate (EPA; 20:5n3), this suggests a shift 
away from lipogenesis to increased lipid oxidation in offspring from over-fed mothers, relative to 
controls.  
 The lipid oxidation profile in offspring from over-fed mothers is also associated with 
cellular membrane degradation. Decreased concentrations of muscle phosphatidylcholines (PC) 
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and phosphatidylethanolamines (PE), including 1-linoleoyl-2-linolenoyl-GPC (18:2/18:3)* and 
1-oleoyl-2-linoleoyl-GPE (18:1/18:2)* were identified compared with control offspring at birth. 
These lipids are key components of the plasma membrane and their depletion may represent 
increased membrane turnover (Van der Veen et al., 2017). A similar profile is produced in 
offspring of restricted-fed mothers that largely involves a distinct subset of PC, including 1-
palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)*. Because these lipids are comprised of similar FA 
speciation, these decreases are likely associated with membrane degradation, relative to control 
animals, as both groups respond to changes in maternal diet.  
Over-feeding during gestation also resulted in changes to the offspring lysolipid pool. 
Lambs from over-fed mothers exhibited depletion in the lysolipid pool at birth, compared with 
control offspring. The majority of the altered phospholipids are ethanolamine and choline 
derivatives (e.g. 1-palmitoleoyl-GPE (16:1)*, 1-palmitoyl-GPE (16:0), 1-linoleoyl-GPC (18:2), 
and 1-arachidonoyl-GPE (20:4n6)*) that are enriched on the inner and outer leaflets of the 
plasma membrane, respectively. Lysolipids, as well as fatty acids, are the natural products 
formed by the hydrolysis of phospholipids and may represent membrane remodeling related to 
phospholipid lysis (Arouri and Mouritsen, 2013). Collectively, offspring of over-fed dams 
exhibit potently increased β-oxidation, particularly at birth. This is of note since increased β-
oxidation in muscle cells is associated with enhanced insulin-stimulated glucose metabolism and 
also protects against fatty acid-induced insulin resistance (Perdormo et al., 2004). The increased 
β-oxidation could be a potential response to increased maternal nutrition.  
 
Maternal restricted-feeding during gestation alters offspring LM metabolome at d 90  
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At d 90, one of the most apparent changes in response to maternal restricted-nutrition was 
alterations to sphingolipid metabolism. Seventeen metabolites involved in sphingolipid 
metabolism were reduced compared with CON. Sphingolipids are an essential part of cellular 
lipid membranes and also serve as second messengers for signal transduction in pathways 
affecting cell growth, differentiation, stress responses, and death (Merrill et al., 1997; Khavander 
and Murshed, 2015). Sphingolipids play a role in the regulation of skeletal muscle development 
and tissue homeostasis (Stoffel, 1999; Aubin et al., 2005; Khavander et al., 2011, 2013; 
Khavander and Murshed, 2015). The broad changes to sphingolipid metabolism demonstrate the 
early effects of maternal restricted-nutrition on muscle development.  
Additionally, there are changes to glutathione metabolism at d 90 in the offspring from 
restricted-fed mothers. Similar to OVER offspring at this time-point, GSH is increased 3.1-fold 
and 2-aminobutyrate is decreased, again suggesting changes in redox status. This could have 
potential negative effects on muscle metabolism. For example, oxidative stress has been shown 
to reduce insulin-stimulated glucose transport and insulin signaling in insulin-sensitive cells such 
as L6 myocytes (Maddux et al., 2001; Rudich et al., 1997; Rudich et al., 1998). Thus, there is 
potential for altered redox status to result in impaired insulin action and altered metabolism 
within the muscle.  
 
Maternal restricted-feeding during gestation alters offspring LM metabolome at d 135 
 In RES offspring at d 135, amino acid metabolism, including histidine, branched chain 
amino acids, glutamate, tyrosine and tryptophan were altered compared with CON. Of particular 
interest is the reduction of glutamate in RES offspring compared with CON. Glutamate is 
essential for protein synthesis in the body (Walker and Van der Donk, 2016), but also has an 
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important role in muscle metabolism (Rennie et al., 1995). Muscle glutamate concentrations are 
correlated with muscle glutathione concentrations, and glutamate plays a determining role in 
glutathione synthesis (Amores-Sanches and Medina 1999; Engelen et al., 2000; Rutten et al., 
2005). The reduction in glutamate concentrations at d 135 is of note since it corresponds with 
changes to glutathione metabolism at this time point. Specifically, GSSG is reduced and 2-
aminobutyrate is increased in RES compared with CON. The reduction in glutamate may be one 
of the mechanisms promoting the change to glutathione metabolism, and therefore redox status, 
at this time point.  
 
Maternal restricted-feeding during gestation alters offspring LM metabolome at birth 
Restricted maternal feeding additionally altered offspring pyrimidine metabolism at birth. 
Pyrimidine intermediates provide important substrates for a wide array of lipids required for 
membrane synthesis and may provide insight into the apparently distinct lipid oxidation profiles 
(Berlin and Oliver, 1975; Lane and Fan, 2015). Here, there was an observed reduction in a 
number of pyrimidine derivatives, including uridine, cytidine, and cytidine diphosphate (CDP). 
Corresponding accumulation of pyrimidine biosynthesis marker orotate, with associated 
depletion of pyrimidine degradation markers β-alanine and 3-aminoisobutyrate, suggests 
increased pyrimidine synthesis. At this time point, there are also decreases to PC and PE pools. 
This could indicate decreased membrane synthesis, particularly in muscle tissue from offspring 
of mothers fed a restricted diet. Taken together with the changes to pyrimidine synthesis, this 
indicates that restricted-feeding may promote attenuated membrane and lipid synthesis, instead 
perhaps favoring anabolic reactions that favor pyrimidine synthesis.  
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Offspring from restricted-fed mothers also exhibit increased concentrations of the 
ketogenic marker 3-hydroxybutyrylcarnitine without associated significant changes in other 
lipids. Ketone bodies play an important role in the adaptation to fasting, serving as an important 
fuel for energy (Puckalska and Crawford, 2017). This increase in 3-hydroxybutyrylcarnitine at 
birth could point to changes in energy utilization within the muscle and a potential for ketosis 
postnatally. Offspring from restricted-fed mothers also exhibited changes to PC and PE 
metabolism, and decreased concentrations of lysolipids, providing some evidence for membrane 
turnover in these offspring. Again this demonstrates that RES offspring show changes to 
membrane lipids and lipid oxidation at birth.  
Maternal nutrient restriction also promotes changes in offspring cholate metabolism. 
Prenatal caloric restriction results in reduced plasma bile acids in offspring mice, correlating with 
low birth weight, glucose intolerance, and obesity (Ma et al., 2017). In the current study, we 
observe divergent changes in cholate and a number of cholate bile salts, including taurocholate, 
and deoxycholate at d 90 in muscle tissue from both RES and OVER offspring. With no obvious 
changes in cholesterol metabolism, these changes likely do not reflect alterations in bile salt 
synthesis, but rather dietary influences that may alter nutrient utilization by the intestine. Further, 
there is evidence of perturbed enterohepatic circulation in the restricted group given increases in 
primary bile salts (e.g., glycochenodeoxycholate, taurochenodeoxycholate, and glycocholate), 
but decreased concentrations of secondary bile salts, particularly taurodeoxycholate. Briefly, 
primary bile acids are conjugated with either taurine or glycine to decrease toxicity and increase 
solubility. In the intestine, a portion of the bile acids could become deconjugated or modified to 
form secondary bile acids which are reabsorbed by enterohepatic circulation. Decreased muscle 
concentrations of secondary bile salts may reflect impairment of this process in the restricted 
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state and possible suggest alterations in fetal or maternal liver function (Joyce et al., 2011). This 
can have a significant impact on body weight gain and growth responses, as shown in a recent 
murine model (Joyce et al., 2011). 
Conclusion 
Although the day of gestation had a greater effect on metabolic change than the 
experimental feeding groups, analysis of the LM metabolome indicated that poor maternal 
nutrition alters muscle metabolism. Muscle tissue from offspring of over-fed mothers exhibited 
evidence of increased lipid oxidation accompanied by increased membrane turnover. Fetuses of 
over- and restricted-fed mothers demonstrated altered amino acid utilization which may result in 
changes to protein synthesis affecting muscle hypertrophy. Additionally, over- and restricted-
feeding also led to altered muscle concentrations of cholate during development. Offspring from 
restricted-fed mothers demonstrated increased utilization of short chain fatty acids and increased 
pyrimidine anabolism at birth. Restricted maternal nutrition may impair enterohepatic circulation 
of bile salts in the offspring, which can have a profound impact on glucose tolerance and 
development. However, further analysis of tissues such as the liver or serum from offspring may 
give a clearer picture of changes to bile salts. Finally, offspring from both over- and restricted-
fed ewes demonstrated altered glutathione metabolism at multiple time points, which could 
indicate altered redox status, and possible oxidative stress.  
 
Future Directions 
Although the metabolome data gave a detailed picture of metabolic change in response to 
maternal diet and day of gestation, further analysis on muscle tissue will provide additional 
insight. Specifically, alterations in glutathione metabolism suggest the need for additional 
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measures of redox status and oxidative stress.  Additionally, the broad changes to lipid 
metabolism in response to maternal diet, especially at birth, indicate that histological analysis of 
lipid content within the muscle tissue may be warranted.  Another area of interest is mTOR 
signaling since this pathway is partially regulated by amino acid sensing. The metabolome 
analysis indicated broad changes to amino acid metabolism in both treatment groups. Therefore, 
there is potential for mTOR to be affected. Analysis of the mTOR pathway could determine if 
the changes to amino acids are actually influencing mTOR regulation of protein synthesis. 
Overall, further analysis of the muscle tissue would support the metabolome findings and 
provided a more detailed understanding of how poor maternal nutrition during gestation is 
affecting muscle development and metabolism.  
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APPENDIX 1 
Staining Protocol for Myosin Heavy Chain 
 
First Day: 
1. Remove cells from incubator 
2. Remove media  
3. Fix wells with 4% paraformaldehyde for 15 minutes  
4. Rinse 2x with PBS  
5. Add blocking solution for 20 minutes  
• 0.2% Triton-X and 5% horse serum in PBS 
6. Add primary antibody  
• MF20 at a dilution of 1:100 
7. Let sit overnight in the dark (wrapped in tinfoil) in the 4C fridge 
 
Next Day: 
1. Rinse 2x with PBS 
2. Add secondary antibody for 1 hour  
• 488 goat-anti-mouse antibody at a dilution of 1:250 
• Hoescht 1:1000 to visualize nuclei  
• Keep in dark  
3. Rinse all wells with PBS 2x 
4. Image same day  
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APPENDIX 2 
Seahorse XF Cell Mito Stress Test Kit Protocol 
 
* Plate cells 24 or 48 hours before assay at correct density depending on experimental protocol 
C2C12 cells were plated at a density of 15,000 cells/ well and allowed to proliferate for 48 hours 
 
Day prior to Assay  
1. Plate cells at previously determined optimized density in the Seahorse XF Cell Culture 
Microplate using the appropriate cell culture medium. 
2. Hydrate a sensor cartridge in Seahorse XF Calibrant at 37oC in a non-CO2 incubator 
overnight. 
 
Day of the Assay  
Prepare Assay Medium  
1. Turn on Seahorse XF analyzer at least one hour before beginning experiment and allow 
the machine to warm up and stabilize.  
2. Prepare assay medium by supplementing Seahorse XF Base Medium with1 mM 
pyruvate, 2 mM glutamine, and 10 mM glucose as a starting point. However, desired 
medium concentration can be varied depending on cell type or in vitro culture conditions. 
3. For 100 mL media add 1 mL pyruvate, 29.28 mg L-glutamine, and 0.4 mL glucose  
4. Warm assay medium to 37oC. 
5. Adjust pH to 7.4 with 0.1 N with NaOH. 
6. Keep at 37oC until ready to use. 
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Prepare Stock Compounds  
Note: Use compounds the same day they are reconstituted. Do not refreeze. Discard any 
remaining compound.  
1. Prepare compounds using constant volume method provided in manual 
2. Remove foil pouch from Seahorse XF cell Mito Stress Test Kit box. Each pouch contains 
reagents sufficient for one Seahorse XF Cell Mito Stress Test in a 24 well Seahorse XF 
Cell Culture Microplate.  
3. Open pouch and remove the three tubes containing oligomycin (blue cap), FCCP (yellow 
cap), and rotenone/ antimycin A (red cap). Place tubes in small tube rack. 
4. Re-suspend contents of each tube with prepared assay medium in volumes described in 
Table 2 of provided booklet with a pipette. Gently pipette up and down (~10 times) to 
solubilize compounds. 
5. Prepare 3 mL of each compound in assay medium. Seahorse recommends using 1 uM of 
oligomycin for most cells.  
 
Load Sensor cartridge  
1. Standard assay – no additional injection: 
• Load compounds into the appropriate ports of a hydrated sensor cartridge for each 
well (75 µL per port) 
o Port A: Oligomycin 
o Port B: FCCP 
o Port C: Rotenone/ antimycin A   
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Prepare Seahorse XF Culture Microplate for Assay  
1. Remove cells from culture microplates from the 37oC CO2 incubator and examine cells 
under the microscope to confirm confluence. 
2. Remove assay medium from water bath. 
3. Change the cell culture growth medium I the cell culture microplate to warmed assay 
medium using a multichannel pipette and place the cell culture microplate into a 37oC 
non-CO2 incubator for 45 minutes to 1 hour prior to the assay. 
 
Run the Seahorse XF Mito Stress Test  
• Open Wave and create new procedure file. Follow the instructions below:  
1. Design new experiment in wave  
▪ Add oligomycin, FCCP, and Rotenone/ Anitmycin-A to injection ports 
▪ Add treatment groups and add to plate map 
2. Select the “Review and Run” tab, then click “Start Run”. 
3. When prompted, place the loaded sensor cartridge with the calibrant plate into the 
instrument, then click “I’m ready”. Calibration will take approximately 15-30 
minutes. Note: remove cartridge lid and verify correct plate orientation. 
4. Following calibration and equilibration of the cell culture microplate, when 
prompted click “I’m ready”. Load the cell culture microplate and click “I’m 
ready” to run the assay.  
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Data Analysis  
• The Seahorse XF Mito Stress Test Report Generator automatically calculates the 
Seahorse XF Cell Mito Stress Test parameters from Wave data that has been exported to 
Excel. It can be used either with standard or modified stress test protocol and provides 
convenient, customizable one-page assay summary. The Report Generator can be 
installed either alongside Wave or directly from the Seahorse Bioscience website.    
• Next day: Isolate DNA from each well to normalize data using the Macherey-Nagel 
NucleoSpin Tissue Kit (50 preps; Ref #740952.50) according to manufacturer 
instructions  
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APPENDIX 3 
Seahorse XF Cell Glycolysis Stress Test Kit Protocol 
 
*Plate cells 24 or 48 hours before assay at correct density depending on experimental protocol 
C2C12 cells were plated at a density of 15,000 cells/ well and allowed to proliferate for 48 hours 
 
Day prior to Assay  
1. Plate cells at previously determined optimized density in the Seahorse XF Cell Culture 
Microplate using the appropriate cell culture medium. 
2. Hydrate a sensor cartridge in Seahorse XF Calibrant at 37oC in a non-CO2 incubator 
overnight. 
 
Day of the Assay  
Prepare Assay Medium  
1. Turn on Seahorse XF Analyzer at least one hour before experiment and let it warm up to 
stabilize.  
2. Prepare assay medium by supplementing Seahorse XF Base Medium with 1 mM 
glutamine as a starting point.  
3. For 100 mL media add 14.6 mg L-glutamine. 
4. Warm assay medium to 37oC. 
5. Adjust pH to 7.4 with 0.1 N with NaOH. 
6. Keep at 37oC until ready to use. 
 
110 
 
Prepare Stock Compounds  
Note: Use compounds the same day they are reconstituted. Do not refreeze. Discard any 
remaining compound.  
1. Prepare compounds using constant volume method described in provided manual 
2. The Seahorse XF Glycolysis Stress Test Kit Includes 6 foil pouches each containing 
oligomycin, 6 vials containing glucose, and 6 vials containing 2-DG. The kit reagents are 
sufficient for 6 XF Glycolysis Stress Test assay in a 24-well Seahorse XF Cell Culture 
Microplate. 
3. Open foil pouch containing oligomycin (light blue cap) and remove 1 vial containing 
glucose (blue cap) and 1 vial containing 2-DG (green cap) from the kit box. 
4. Re-suspend each component with prepared assay medium in volumes described in 3 with 
p1000 pipette. Gently pipette up and down (~10 times) to solubilize the compounds. 
Vortex the 2-DG to ensure that it goes into solution.  
 
Load Sensor cartridge  
1. Standard assay – no additional injection: 
• Load compounds into the appropriate ports of a hydrated sensor cartridge for each 
well (75 µL per port) 
o Port A: Glucose  
o Port B: Oligomycin 
o Port C: 2-DG   
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Prepare Seahorse XF Culture Microplate for Assay  
1. Remove cells from culture microplates from the 37oC CO2 incubator and examine cells 
under the microscope to confirm confluence. 
2. Remove assay medium from water bath. 
3. Change the cell culture growth medium I the cell culture microplate to warmed assay 
medium using a multichannel pipette and place the cell culture microplate into a 37oC 
non-CO2 incubator for 45 minutes to 1 hour prior to the assay.  
 
Run the Seahorse XF Glycolysis Stress Test  
• Open Wave and create new procedure file. Follow the instructions below:  
1. Design new experiment in wave  
▪ Add glucose, oligomycin, and 2-DG to injection ports 
▪ Add treatment groups and add to plate map 
2. Select the “Review and Run” tab, then click “Start Run”. 
3. When prompted, place the loaded sensor cartridge with the calibrant plate into the 
instrument, then click “I’m ready”. Calibration will take approximately 15-30 
minutes. Note: remove cartridge lid and verify correct plate orientation. 
4. Following calibration and equilibration of the cell culture microplate, when 
prompted click “I’m ready”. Load the cell culture microplate and click “I’m 
ready” to run the assay.  
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Data Analysis  
• The Seahorse XF Glycolysis Stress Test Report Generator automatically calculates the 
Seahorse XF Cell Mito Stress Test parameters from Wave data that has been exported to 
Excel. It can be used either with standard or modified stress test protocol and provides 
convenient, customizable one-page assay summary. The Report Generator can be 
installed either alongside Wave or directly from the Seahorse Bioscience website.    
• Next day: Isolate DNA from each well to normalize data using the Macherey-Nagel 
NucleoSpin Tissue Kit (50 preps; Ref #740952.50) according to manufacturer 
instructions  
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